Criticalkare Pharma

Daily Dose Strength	140mg
Brand	Nitib
Strength	140 mg
Pack Size	30 Capsules
Indication	SLL
Form	Capsule
Storage Condition	Store below 30 degree Celsius
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Nitib 140mg capsule consists of the active ingredient Ibrutinib. It is indicated to treat blood cancers such as mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (CLL), Waldenstrom’s macroglobulinemia, and Marginal zone lymphoma (MZL). These are cancers of the white blood cells called lymphocytes that are part of the immune system. They differ from each other by the location where cancer occurs, type of lymphocytes affected, and certain other factors

Nitib 140mg capsule is also used to treat chronic graft versus host disease (cGvHD) after the failure of systemic therapy. During allogeneic stem cell transplantation, the patient receives stem cells from the donor. GvHD occurs when donor cells attack the patient's cells as foreign.. Before taking Nitib 140mg  Capsule, you need to talk with your physician if you have bleeding problems, infection, liver problems, heart problems, or intolerance to some sugars. This medication is not recommended for adolescents and children. 

Uses

• Mantle cell lymphoma
• Chronic lymphocytic leukemia (Blood cancer)
• Small lymphocytic lymphoma
• Waldenstrom’s macroglobulinemia
• Chronic graft vs. host disease after failure of systemic therapy

More Information

• Store the capsules in the original packaging at room temperature (20-25°C).

Safety Advices   Pregnancy  

This medicine can harm the unborn baby. Do not take Nitib 140mg Capsule unless your physician instructs you to take it. Inform your physician before starting this treatment if you are pregnant or think you might be pregnant.   

Breast Feeding  

Do not breastfeed while you are under Nitib 140mg capsule and for at least one week after the last dose. Consult your physician for risks and benefits.  

Lungs  

Nitib 140mg capsule may cause interstitial lung disease. So if you have any respiratory disorder, inform your doctor before starting the treatment.   

Liver  

Inform your physician before starting this treatment if you have liver problems, including hepatitis B infection.  Nitib 140mg capsule could cause the reactivation of the hepatitis B virus, which makes the condition fatal.  

Alcohol  

It is unknown whether it is safe to consume alcohol with the Nitib 140mg capsule. Please consult your doctor.  

Driving  

Nitib 140mg capsule may cause dizziness or tiredness. Avoid driving or operating machines if you feel dizzy or tired.

Side Effects

• Bleeding problems
• Infections
• Decrease in blood cell counts
• Heart problems
• High BP
• Secondary cancer
• Tumor lysis syndrome
• Severe allergic reactions

• Nausea, vomiting, diarrhea
• Tiredness
• Muscle and bone pain
• Rash and bruising
• Mouth sores
• Pneumonia
• Fever, chills
• Breathlessness
• Constipation
• Dizziness
• Body pain
• Swollen ankles and feet
• Increased creatinine levels in blood
• Heavier periods and blood in urine
• Blurred vision
• Weakness and numbness

Strength	3.75 mg
Formulation Type	Depot
Brand	Bdsure
Packaging Type	Vial
Therapeutic Indication	Prostate Cancer
Manufacturer	BDR
Pack Size	1 ml
Country of Origin	Made in India

Bdsure 3.75mg injection consists of the active ingredient Leuprolide acetate. It belongs to the class of medicines called Gonadotropin Releasing Hormone (GnRH) agonists. This injection treats prostate cancer in men, hormone-responsive breast cancer, endometriosis (tissue that usually lines the interior of the uterus grows outside of it), and uterine fibroids (noncancerous growths of the uterus) in women. This medicine is also used for the treatment of premature puberty, which is characterized by early physical development in children due to hormonal imbalances.Do not receive this injection if you are allergic to Bdsure 3.75mg or its ingredients, including Goserelin and Triptorlin. Before receiving this medicine, inform your physician if you have a liver or kidney impairment. Inform your doctor if you have undiagnosed abnormal uterine bleeding. Do not take this treatment if you are pregnant or planning to get pregnant. During the treatment, the existing symptoms may worsen due to the sex steroid increase in the body. Talk to your physician for more concerns. Report to your doctor if your child has a progressive brain tumor.  Uses Prostate cancerHormone-responsive breast cancer in perimenopausal (around menopause) womenEndometriosis (a painful illness in which the tissue that normally lines the inside of the uterus grows outside of your uterus)Central precocious puberty (a child’s body begins to change into an adult too soon caused by a release of certain hormones)More Information Keep Bdsure 3.75mg out of sight and reach of children.Store in a cool, dry place, away from direct heat and light.Store below 25°CDo not refrigerate or freeze.Safety Advices   Pregnancy  It is unsafe to use Bdsure 3.75mg injection because it is contraindicated in pregnant women. Tell your doctor if you are pregnant or planning to get pregnant before taking this treatment.  Breast Feeding  Bdsure 3.75mg injection is contraindicated in breastfeeding women. Inform your doctor if you are breastfeeding before taking this injection.  Lungs  It is unknown whether Bdsure 3.75mg is safe for patients with lung problems. Notify your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.  LiverBdsure 3.75mg should be used cautiously in patients with liver impairment. Consult your doctor before receiving it. Notify your doctor about underlying liver conditions.  Alcohol  Consuming alcohol during the Bdsure 3.75mg injection treatment may increase the risk of thinning bones (osteoporosis). Hence caution should be taken. Consult your doctor for more information.  Driving  Bdsure 3.75mg Injection can cause drowsiness, visual disturbances, or dizziness. It is unsafe; hence avoid driving if you are unwell.Side Effects Severe rash, itchingShortness or difficulty of breathCough with bloodPulmonary embolismSevere headacheAltered blood sugar and cholesterol levelsInjection site reactionsLoss of appetiteAbnormal liver functionSwelling in the ankle or handDifficulty sleeping, headacheMood swings, depressionWeight changesNausea, vomitingVaginal dryness, bleedingLoss of interest in sexual intercourseHot flushesBone pain, muscle weaknessBreast tenderness

Strength	3.75 mg
Formulation Type	Depot
Brand	Elurolide
Packaging Type	Vial
Therapeutic Indication	Prostate Cancer
Manufacturer	Samarth
Pack Size	1 ml
Country of Origin	Made in India

Eurolide Depot 3.75mg injection consists of the active ingredient Leuprolide acetate. It belongs to the class of medicines called Gonadotropin Releasing Hormone (GnRH) agonists. This injection treats prostate cancer in men, hormone-responsive breast cancer, endometriosis (tissue that usually lines the interior of the uterus grows outside of it), and uterine fibroids (noncancerous growths of the uterus) in women. This medicine is also used for the treatment of premature puberty, which is characterized by early physical development in children due to hormonal imbalances.Do not receive this injection if you are allergic to Eurolide Depot 3.75mg or its ingredients, including Goserelin and Triptorlin. Before receiving this medicine, inform your physician if you have a liver or kidney impairment. Inform your doctor if you have undiagnosed abnormal uterine bleeding. Do not take this treatment if you are pregnant or planning to get pregnant. During the treatment, the existing symptoms may worsen due to the sex steroid increase in the body. Talk to your physician for more concerns. Report to your doctor if your child has a progressive brain tumor.  Uses Prostate cancerHormone-responsive breast cancer in perimenopausal (around menopause) womenEndometriosis (a painful illness in which the tissue that normally lines the inside of the uterus grows outside of your uterus)Central precocious puberty (a child’s body begins to change into an adult too soon caused by a release of certain hormones)More Information Keep Eurolide Depot 3.75mg out of sight and reach of children.Store in a cool, dry place, away from direct heat and light.Store below 25°CDo not refrigerate or freeze.Safety Advices Pregnancy  It is unsafe to use Eurolide Depot 3.75mg injection because it is contraindicated in pregnant women. Tell your doctor if you are pregnant or planning to get pregnant before taking this treatment.   Breast Feeding  Eurolide Depot 3.75mg injection is contraindicated in breastfeeding women. Inform your doctor if you are breastfeeding before taking this injection.  Lungs  It is unknown whether Eurolide Depot 3.75mg is safe for patients with lung problems. Notify your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.  Liver  Eurolide Depot 3.75mg should be used cautiously in patients with liver impairment. Consult your doctor before receiving it. Notify your doctor about underlying liver conditions.   Alcohol  Consuming alcohol during the Eurolide Depot 3.75mg injection treatment may increase the risk of thinning bones (osteoporosis). Hence caution should be taken. Consult your doctor for more information.  Driving  Eurolide Depot 3.75mg Injection can cause drowsiness, visual disturbances, or dizziness. It is unsafe; hence avoid driving if you are unwell.Side Effects Severe rash, itchingShortness or difficulty of breathCough with bloodPulmonary embolismSevere headacheAltered blood sugar and cholesterol levelsInjection site reactionsLoss of appetiteAbnormal liver functionSwelling in the ankle or handDifficulty sleeping, headacheMood swings, depressionWeight changesNausea, vomitingVaginal dryness, bleedingLoss of interest in sexual intercourseHot flushesBone pain, muscle weaknessBreast tenderness

Strength	3.75 mg
Formulation Type	Depot
Brand	Luprova
Packaging Type	Vial
Therapeutic Indication	Prostate Cancer
Manufacturer	Celeon
Pack Size	1 ml
Country of Origin	Made in India

Luprova 3.75mg injection consists of the active ingredient Leuprolide acetate. It belongs to the class of medicines called Gonadotropin Releasing Hormone (GnRH) agonists. This injection treats prostate cancer in men, hormone-responsive breast cancer, endometriosis (tissue that usually lines the interior of the uterus grows outside of it), and uterine fibroids (noncancerous growths of the uterus) in women. This medicine is also used for the treatment of premature puberty, which is characterized by early physical development in children due to hormonal imbalances.

Do not receive this injection if you are allergic to Luprova 3.75mg or its ingredients, including Goserelin and Triptorlin. Before receiving this medicine, inform your physician if you have a liver or kidney impairment. Inform your doctor if you have undiagnosed abnormal uterine bleeding. Do not take this treatment if you are pregnant or planning to get pregnant. During the treatment, the existing symptoms may worsen due to the sex steroid increase in the body. Talk to your physician for more concerns. Report to your doctor if your child has a progressive brain tumor.  

Uses

• Prostate cancer
• Hormone-responsive breast cancer in perimenopausal (around menopause) women
• Endometriosis (a painful illness in which the tissue that normally lines the inside of the uterus grows outside of your uterus)
• Central precocious puberty (a child’s body begins to change into an adult too soon caused by a release of certain hormones) 

More Information

• Keep Luprova 3.75mg out of sight and reach of children.
• Store in a cool, dry place, away from direct heat and light.
• Store below 25°C
• Do not refrigerate or freeze.

Safety Advices   Pregnancy  

It is unsafe to use Luprova 3.75mg injection because it is contraindicated in pregnant women. Tell your doctor if you are pregnant or planning to get pregnant before taking this treatment.  

Breast Feeding  

Luprova 3.75mg injection is contraindicated in breastfeeding women. Inform your doctor if you are breastfeeding before taking this injection.  

Lungs  

It is unknown whether Luprova 3.75mg is safe for patients with lung problems. Notify your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.  

Liver  

Luprova 3.75mg should be used cautiously in patients with liver impairment. Consult your doctor before receiving it. Notify your doctor about underlying liver conditions.  

Alcohol  

Consuming alcohol during the Luprova 3.75mg injection treatment may increase the risk of thinning bones (osteoporosis). Hence caution should be taken. Consult your doctor for more information.  

Driving  

Luprova 3.75mg Injection can cause drowsiness, visual disturbances, or dizziness. It is unsafe; hence avoid driving if you are unwell.

Side Effects

• Severe rash, itching
• Shortness or difficulty of breath
• Cough with blood
• Pulmonary embolism
• Severe headache

• Altered blood sugar and cholesterol levels
• Injection site reactions
• Loss of appetite
• Abnormal liver function
• Swelling in the ankle or hand
• Difficulty sleeping, headache
• Mood swings, depression
• Weight changes
• Nausea, vomiting
• Vaginal dryness, bleeding
• Loss of interest in sexual intercourse
• Hot flushes
• Bone pain, muscle weakness
• Breast tenderness

Daily Dose Strength	140mg
Brand	Imbruvica
Strength	140 mg
Pack Size	120 Capsules
Indication	CLL
Form	Capsule
Storage Condition	Store below 30 degree Celsius
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Imbruvica 140mg capsule consists of the active ingredient Ibrutinib. It is indicated to treat blood cancers such as mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (CLL), Waldenstrom’s macroglobulinemia, and Marginal zone lymphoma (MZL). These are cancers of the white blood cells called lymphocytes that are part of the immune system. They differ from each other by the location where cancer occurs, type of lymphocytes affected, and certain other factors

Imbruvica 140mg capsule is also used to treat chronic graft versus host disease (cGvHD) after the failure of systemic therapy. During allogeneic stem cell transplantation, the patient receives stem cells from the donor. GvHD occurs when donor cells attack the patient's cells as foreign.. Before taking Imbruvica 140mg  Capsule, you need to talk with your physician if you have bleeding problems, infection, liver problems, heart problems, or intolerance to some sugars. This medication is not recommended for adolescents and children. 

Uses

• Mantle cell lymphoma
• Chronic lymphocytic leukemia (Blood cancer)
• Small lymphocytic lymphoma
• Waldenstrom’s macroglobulinemia
• Chronic graft vs. host disease after failure of systemic therapy

More Information

• Store the capsules in the original packaging at room temperature (20-25°C).

Safety Advices Pregnancy  

This medicine can harm the unborn baby. Do not take Imbruvica 140mg Capsule unless your physician instructs you to take it. Inform your physician before starting this treatment if you are pregnant or think you might be pregnant.   

Breast Feeding  

Do not breastfeed while you are under Imbruvica 140mg capsule and for at least one week after the last dose. Consult your physician for risks and benefits.  

Lungs  

Imbruvica 140mg capsule may cause interstitial lung disease. So if you have any respiratory disorder, inform your doctor before starting the treatment.   

Liver  

Inform your physician before starting this treatment if you have liver problems, including hepatitis B infection.  Imbruvica 140mg capsule could cause the reactivation of the hepatitis B virus, which makes the condition fatal.  

Alcohol  

It is unknown whether it is safe to consume alcohol with the Imbruvica 140mg capsule. Please consult your doctor.  

Driving  

Imbruvica 140mg capsule may cause dizziness or tiredness. Avoid driving or operating machines if you feel dizzy or tired.

Side Effects

• Bleeding problems
• Infections
• Decrease in blood cell counts
• Heart problems
• High BP
• Secondary cancer
• Tumor lysis syndrome
• Severe allergic reactions

• Nausea, vomiting, diarrhea
• Tiredness
• Muscle and bone pain
• Rash and bruising
• Mouth sores
• Pneumonia
• Fever, chills
• Breathlessness
• Constipation
• Dizziness
• Body pain
• Swollen ankles and feet
• Increased creatinine levels in blood
• Heavier periods and blood in urine
• Blurred vision
• Weakness and numbness

Daily Dose Strength	140mg
Brand	Imbruvica
Strength	140 mg
Pack Size	90 Capsules
Indication	CLL
Form	Capsule
Storage Condition	Store below 30 degree Celsius
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Imbruvica 140mg capsule consists of the active ingredient Ibrutinib. It is indicated to treat blood cancers such as mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (CLL), Waldenstrom’s macroglobulinemia, and Marginal zone lymphoma (MZL). These are cancers of the white blood cells called lymphocytes that are part of the immune system. They differ from each other by the location where cancer occurs, type of lymphocytes affected, and certain other factors

Imbruvica 140mg capsule is also used to treat chronic graft versus host disease (cGvHD) after the failure of systemic therapy. During allogeneic stem cell transplantation, the patient receives stem cells from the donor. GvHD occurs when donor cells attack the patient's cells as foreign.. Before taking Imbruvica 140mg  Capsule, you need to talk with your physician if you have bleeding problems, infection, liver problems, heart problems, or intolerance to some sugars. This medication is not recommended for adolescents and children. 

Uses

• Mantle cell lymphoma
• Chronic lymphocytic leukemia (Blood cancer)
• Small lymphocytic lymphoma
• Waldenstrom’s macroglobulinemia
• Chronic graft vs. host disease after failure of systemic therapy

More Information

• Store the capsules in the original packaging at room temperature (20-25°C).

Safety Advices   Pregnancy  

This medicine can harm the unborn baby. Do not take Imbruvica 140mg Capsule unless your physician instructs you to take it. Inform your physician before starting this treatment if you are pregnant or think you might be pregnant.  

Breast Feeding  

Do not breastfeed while you are under Imbruvica 140mg capsule and for at least one week after the last dose. Consult your physician for risks and benefits.  

Lungs  

Imbruvica 140mg capsule may cause interstitial lung disease. So if you have any respiratory disorder, inform your doctor before starting the treatment.   

Liver  

Inform your physician before starting this treatment if you have liver problems, including hepatitis B infection.  Imbruvica 140mg capsule could cause the reactivation of the hepatitis B virus, which makes the condition fatal.  

Alcohol  

It is unknown whether it is safe to consume alcohol with the Imbruvica 140mg capsule. Please consult your doctor.  

Driving  

Imbruvica 140mg capsule may cause dizziness or tiredness. Avoid driving or operating machines if you feel dizzy or tired.

Side Effects

• Bleeding problems
• Infections
• Decrease in blood cell counts
• Heart problems
• High BP
• Secondary cancer
• Tumor lysis syndrome
• Severe allergic reactions

• Nausea, vomiting, diarrhea
• Tiredness
• Muscle and bone pain
• Rash and bruising
• Mouth sores
• Pneumonia
• Fever, chills
• Breathlessness
• Constipation
• Dizziness
• Body pain
• Swollen ankles and feet
• Increased creatinine levels in blood
• Heavier periods and blood in urine
• Blurred vision
• Weakness and numbness

Daily Dose Strength	140mg
Brand	Ibrushil
Strength	140 mg
Pack Size	120 Capsules
Indication	CLL
Form	Capsule
Storage Condition	Store below 30 degree Celsius
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Ibrushil 140mg capsule consists of the active ingredient Ibrutinib. It is indicated to treat blood cancers such as mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (CLL), Waldenstrom’s macroglobulinemia, and Marginal zone lymphoma (MZL). These are cancers of the white blood cells called lymphocytes that are part of the immune system. They differ from each other by the location where cancer occurs, type of lymphocytes affected, and certain other factors

Ibrushil 140mg capsule is also used to treat chronic graft versus host disease (cGvHD) after the failure of systemic therapy. During allogeneic stem cell transplantation, the patient receives stem cells from the donor. GvHD occurs when donor cells attack the patient's cells as foreign.. Before taking Ibrushil 140mg  Capsule, you need to talk with your physician if you have bleeding problems, infection, liver problems, heart problems, or intolerance to some sugars. This medication is not recommended for adolescents and children. 

Uses

• Mantle cell lymphoma
• Chronic lymphocytic leukemia (Blood cancer)
• Small lymphocytic lymphoma
• Waldenstrom’s macroglobulinemia
• Chronic graft vs. host disease after failure of systemic therapy

More Information

• Store the capsules in the original packaging at room temperature (20-25°C).

Safety Advices   Pregnancy  

This medicine can harm the unborn baby. Do not take Ibrushil 140mg Capsule unless your physician instructs you to take it. Inform your physician before starting this treatment if you are pregnant or think you might be pregnant.   

Breast Feeding  

Do not breastfeed while you are under Ibrushil 140mg capsule and for at least one week after the last dose. Consult your physician for risks and benefits.  

Lungs  

Ibrushil 140mg capsule may cause interstitial lung disease. So if you have any respiratory disorder, inform your doctor before starting the treatment.   

Liver

Inform your physician before starting this treatment if you have liver problems, including hepatitis B infection.  Ibrushil 140mg capsule could cause the reactivation of the hepatitis B virus, which makes the condition fatal.  

Alcohol

It is unknown whether it is safe to consume alcohol with the Ibrushil 140mg capsule. Please consult your doctor.  

Driving

Ibrushil 140mg capsule may cause dizziness or tiredness. Avoid driving or operating machines if you feel dizzy or tired.

Side Effects

• Bleeding problems
• Infections
• Decrease in blood cell counts
• Heart problems
• High BP
• Secondary cancer
• Tumor lysis syndrome
• Severe allergic reactions

• Nausea, vomiting, diarrhea
• Tiredness
• Muscle and bone pain
• Rash and bruising
• Mouth sores
• Pneumonia
• Fever, chills
• Breathlessness
• Constipation
• Dizziness
• Body pain
• Swollen ankles and feet
• Increased creatinine levels in blood
• Heavier periods and blood in urine
• Blurred vision
• Weakness and numbness

Daily Dose Strength	140mg
Brand	Bdrut
Strength	140 mg
Pack Size	30 Capsules
Indication	CLL
Form	Capsule
Storage Condition	Store below 30 degree celsius
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Bdbrut 140mg capsule consists of the active ingredient Ibrutinib. It is indicated to treat blood cancers such as mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (CLL), Waldenstrom’s macroglobulinemia, and Marginal zone lymphoma (MZL). These are cancers of the white blood cells called lymphocytes that are part of the immune system. They differ from each other by the location where cancer occurs, type of lymphocytes affected, and certain other factors

Bdbrut 140mg capsule is also used to treat chronic graft versus host disease (cGvHD) after the failure of systemic therapy. During allogeneic stem cell transplantation, the patient receives stem cells from the donor. GvHD occurs when donor cells attack the patient's cells as foreign.. Before taking Bdbrut 140mg  Capsule, you need to talk with your physician if you have bleeding problems, infection, liver problems, heart problems, or intolerance to some sugars. This medication is not recommended for adolescents and children. 

Uses

• Mantle cell lymphoma
• Chronic lymphocytic leukemia (Blood cancer)
• Small lymphocytic lymphoma
• Waldenstrom’s macroglobulinemia
• Chronic graft vs. host disease after failure of systemic therapy

More Information

• Store the capsules in the original packaging at room temperature (20-25°C).

Safety Advices Pregnancy  

This medicine can harm the unborn baby. Do not take Bdbrut 140mg Capsule unless your physician instructs you to take it. Inform your physician before starting this treatment if you are pregnant or think you might be pregnant.   

Breast Feeding  

Do not breastfeed while you are under Bdbrut 140mg capsule and for at least one week after the last dose. Consult your physician for risks and benefits.  

Lungs  

Bdbrut 140mg capsule may cause interstitial lung disease. So if you have any respiratory disorder, inform your doctor before starting the treatment.   

Liver  

Inform your physician before starting this treatment if you have liver problems, including hepatitis B infection.  Bdbrut 140mg capsule could cause the reactivation of the hepatitis B virus, which makes the condition fatal.  

Alcohol  

It is unknown whether it is safe to consume alcohol with the Bdbrut 140mg capsule. Please consult your doctor.  

Driving  

Bdbrut 140mg capsule may cause dizziness or tiredness. Avoid driving or operating machines if you feel dizzy or tired.

Side Effects

• Bleeding problems
• Infections
• Decrease in blood cell counts
• Heart problems
• High BP
• Secondary cancer
• Tumor lysis syndrome
• Severe allergic reactions

• Nausea, vomiting, diarrhea
• Tiredness
• Muscle and bone pain
• Rash and bruising
• Mouth sores
• Pneumonia
• Fever, chills
• Breathlessness
• Constipation
• Dizziness
• Body pain
• Swollen ankles and feet
• Increased creatinine levels in blood
• Heavier periods and blood in urine
• Blurred vision
• Weakness and numbness

Strength	25 mg
Packaging Size	10 Tablets
Brand	Xmalon
Composition	Exemestane
Dosage Form	Tablet
Form	Tablet
Prescription	Prescription
Storage Condition	Store below 30 DegreeC
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Xmalon 25mg tablet is an anticancer drug with the active ingredient Exemestane. It belongs to the medication class known as aromatase inhibitors. In postmenopausal women, it is used to treat hormone-dependent early breast cancer after completing 2-3 years of treatment with Tamoxifen. In addition, it also treats hormone-dependent advanced breast cancer.  Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. Do not take this medicine if you are allergic to Exemestane or any of the other ingredients of this medicine and if you have not been through the menopause stage, also if you think you are pregnant or breastfeeding. 

Xmalon 25mg tablet is not recommended for adolescents and children under the age of 18. Inform your doctor before starting the treatment, if you have problems with your liver or kidney or if you have a history of the bone condition as this medicine can make you lose mineral content and decrease its strength. Inform your doctor if you take any other medicine while under this treatment. Regular checking will be conducted to monitor the vitamin D level, if your level is below normal you will be given vitamin D.  You need to tell your doctor about all the medications you are taking recently before taking this medicine. Use effective birth control during the treatment with this medicine. 

Uses of Xmalon 25mg Tablet

• Breast cancer

Therapeutic Effects of Xmalon 25mg Tablet

Xmalon 25mg inhibits the enzyme aromatase, which is responsible for the conversion of androgens (male hormones) to estrogen (female hormones). By inhibiting aromatase, Xmalon 25mg reduces the levels of estrogen in the body. This can stop or reduce the growth of different hormone-sensitive breast cancer cells, which depends on estrogen. 

More Information

• Keep the tablets away from light and moisture.
• Keep the tablets out of the reach of children and animals.
• This medicine does not require any special storage conditions.

Safety Advices Pregnancy

Do not take this Xmalon 25mg if you are pregnant because it may cause harm to the unborn baby. Consult your doctor before starting the treatment.   

Breast Feeding  

It is unsafe to breastfeed while taking Xmalon 25mg because it can cause toxicity to the baby. Please consult your physician for more advice.  

Lungs

It is unknown if patients with lung conditions can consume Xmalon 25mg. So, before beginning the treatment, consult your doctor if you have any lung conditions.  

Liver

Inform your physician about any underlying liver disorders before taking Xmalon 25mg, as this medication should be used with caution in liver disease patients.  

Alcohol

It is unknown if drinking alcohol while taking an Xmalon 25mg tablet is safe. Please speak with your physician.  

Driving

Xmalon 25mg may affect the ability to drive in some patients. Hence, it is advised to avoid driving if you feel tired or weak while taking this injection.

Side Effects

• Lowered white blood cell (leukopenia)
• Reduction of platelets in the blood
• Allergic reaction
• Difficulty in breathing

• Numbness and hand pain (Carpal tunnel syndrome)
• Depression
• High levels of liver enzymes
• Diarrhea, Nausea
• Depression
• Joint and back pain
• Fatigue
• Abdomen pain
• Swelling in hands and feets
• Muscle pain
• Tingling, pain, coldness, weakness in parts of the hand.

Strength	1 g
Dose/Strength	1000 mg
Injection Type	Lyophilized Powder
Composition	Gemcitabine
Packaging Size	Vial
Brand	Innogem
Route	IV
Packaging Type	Vial
Storage Condition	Store below 30 DegreeC
Prescription/Non prescription	Prescription
Manufacturer	BDR Pharmaceuticals Internationals Pvt
Form	Injection
Shelf Life	24 Months
Usage/Application	Personal
Country of Origin	Made in India

Innogem 1000mg injection is a chemotherapy medication containing the active ingredient gemcitabine. It is used to treat bladder cancer, breast cancer, ovarian cancer, pancreatic cancer, and non-small cell lung cancer. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. Talk to your doctor if you have heart disease, liver disorders, kidney disorders, recently had radiotherapy, or vaccinated before taking this medicine. 

Innogem 1000mg injection is not recommended for adolescents and children under the age of 18. Your doctor will assess your blood cell counts and kidney and liver function each time you are given this medicine. Use effective birth control during the treatment and at least six months after the last dose. This injection may impair fertility in male patients. Men taking this medicine are advised not to father a child during the treatment and for 6 months after the treatment. 

Tell your physician if you are on a salt-controlled diet, as this medicine contains sodium. Report to your doctor immediately if you experience shortness of breath, wheezing, changes in color or volume of urine, bleeding, or upper abdominal pain while taking Innogem 1000mg injection.

Uses of Innogem 1000mg Injection

Innogem 1000mg injection is used to treat

• Bladder cancer, in combination with cisplatin
• Ovarian cancer, in combination with carboplatin
• Breast cancer, in combination with paclitaxel
• Pancreatic cancer
• Non-small cell lung cancer (NSCLC), alone or in combination with cisplatin

 

More Information

• Keep Innogem 1000mg injection out of sight and reach of children.
• This medicine does not require any special storage conditions.
• Do not refrigerate or freeze.

Safety Advices Pregnancy  

Innogem 1000mg injection can cause harm to your unborn baby. Tell your doctor if you are pregnant or planning to get pregnant before taking this treatment.   

Breast Feeding  

You must not breastfeed while being treated with Innogem 1000mg injection. Inform your doctor if you are breastfeeding before taking this injection.  

Lungs  

Innogem 1000mg injection is used cautiously in a patient with a lung disorder. Inform your doctor if you have any lung disease.   

Liver  

You need to tell your doctor if you have any liver disorders before taking Innogem 1000mg injection. Your doctor may decide to adjust the dose or delay treating you depending on your liver function.  

Alcohol  

It is not advised to take alcohol while under this treatment because Innogem 1000mg may cause drowsiness and sleepiness.  Talk to your doctor for more information.  

Driving  

Innogem 1000mg injection could affect your ability to drive. Avoid driving while taking this medicine. Talk to your doctor for more information. 

Side Effects

• Pulmonary toxicity (shortness of breath, wheezing, cough)
• Hemolytic-uremic syndrome (Changes in the volume or colour of urine, increased bruising, or bleeding)
• Pain or tenderness in the upper abdomen
• Allergic reactions, rashes, fever, swelling or sores in the mouth

• Nausea, vomiting
• Low blood cell count
• Loss of appetite
• Hair loss
• Swelling of ankles, feet, and fingers
• Insomnia
• Constipation, diarrhea
• Headache
• Runny nose, chills
• Muscle pain, back pain
• Sweating
• hair loss
• liver problems
• blood in urine
• abnormal urine test
• Oedema (swelling of ankles, fingers, feet, face)

Strength	5 mg
Composition	Axitinib
Pack Size	28 Tablets
Brand	Axpero
Form	Tablet
Usage	Kidney Cancer
Storage Condition	Store below 30 DegreeC
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Axpero 5mg tablet is an anticancer drug belonging to the class of tyrosine kinase inhibitors, containing the active ingredient Axitinib. It is used to treat advanced kidney cancer which is also known as renal cell carcinoma that originates in the cells of the kidney.

It is not recommended to undergo surgical procedures while on treatment with this drug due to the high risk of bleeding. Tell your physician before you undergo surgery or dental procedures. Get immediate medical attention if you experience itching, vision changes, confusion, or dizziness. This medicine may cause harm to an unborn baby. Tell your healthcare provider before beginning this treatment if you are pregnant or planning to have a baby. It is advised for both men and women to follow proper contraceptive methods during and one week after the last dose of this drug. Avoid breastfeeding your baby while you are on the treatment as this drug can impact the growth and development of the baby by passing into the breast milk. If you get mouth sores, weight loss, and have itchy skin, consult with your doctor.

This drug is not recommended for adolescents and children under the age of 18. Contact your doctor immediately if you experience shortness of breath, chest pain, or worsening cough. During the treatment, your doctor may periodically monitor your white blood cell counts, platelets, blood sugar, electrolytes, and kidney parameters to prevent serious complications. Some GI symptoms may also develop during the treatment such as diarrhea, nausea, vomiting, and constipation. It is necessary to report to your doctor right away.

Uses of Axpero 5mg Tablet

• Advanced kidney cancer

More Information

• Store Axpero 5mg tablet in the original package at room temperature (20°C to 25°C).
• Keep it out of reach from children.

Safety Advices Pregnancy  

Axpero 5mg tablet is not recommended for pregnant women as it may cause fetal harm. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.  

Breast Feeding  

It is unsafe to breastfeed during the treatment with Axpero 5mg tablet because it may cause harm to the baby. Please consult your doctor before breastfeeding.  

Lungs  

It is not known whether Axpero 5mg tablet can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.  

Liver  

Inform your doctor if you have any liver problems before taking Axpero 5mg tablet. Regular monitoring of liver function tests is recommended.  

Alcohol  

Consuming alcohol may affect the effectiveness of Axpero 5mg tablet. Stop consuming alcohol if you are taking this medicine.  

Driving  

It is unsafe to drive vehicles or operate heavy machinery after taking Axpero 5mg tablets, it may cause dizziness and impair your concentration.

Side Effects

• Extreme tiredness and swelling
• Pressure or pain in the chest, arms, back, neck or jaw
• Breathlessness
• Numbness and weakness on one side of the body
• Difficulty speaking or communicating verbally
• Headache
• Vision changes or dizziness
• Serious bleeding problems like black tarry stools, bloody cough or bloody sputum
• Severe stomach pain
• High blood pressure

• Kidney problems
• Dehydration
• Hyper-active thyroid gland
• Sore throat
• Loss of appetite
• Joint pain
• Lack of energy
• Weight loss
• Constipation
• Mouth sores
• Skin itching, redness of skin and hair loss

Strength	5 mg
Composition	Axitinib
Pack Size	28 Tablets
Brand	Inlybest
Form	Tablet
Usage	Kidney Cancer
Storage Condition	Store below 30 DegreeC
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Inlybest 5mg tablet is an anticancer drug belonging to the class of tyrosine kinase inhibitors, containing the active ingredient Axitinib. It is used to treat advanced kidney cancer which is also known as renal cell carcinoma that originates in the cells of the kidney.

It is not recommended to undergo surgical procedures while on treatment with this drug due to the high risk of bleeding. Tell your physician before you undergo surgery or dental procedures. Get immediate medical attention if you experience itching, vision changes, confusion, or dizziness. This medicine may cause harm to an unborn baby. Tell your healthcare provider before beginning this treatment if you are pregnant or planning to have a baby. It is advised for both men and women to follow proper contraceptive methods during and one week after the last dose of this drug. Avoid breastfeeding your baby while you are on the treatment as this drug can impact the growth and development of the baby by passing into the breast milk. If you get mouth sores, weight loss, and have itchy skin, consult with your doctor.

This drug is not recommended for adolescents and children under the age of 18. Contact your doctor immediately if you experience shortness of breath, chest pain, or worsening cough. During the treatment, your doctor may periodically monitor your white blood cell counts, platelets, blood sugar, electrolytes, and kidney parameters to prevent serious complications. Some GI symptoms may also develop during the treatment such as diarrhea, nausea, vomiting, and constipation. It is necessary to report to your doctor right away.

Uses of Inlybest 5mg Tablet

• Advanced kidney cancer

More Information

• Store Inlybest 5mg tablet in the original package at room temperature (20°C to 25°C).
• Keep it out of reach from children.

Safety Advices   Pregnancy  

Inlybest 5mg tablet is not recommended for pregnant women as it may cause fetal harm. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.  

Breast Feeding  

It is unsafe to breastfeed during the treatment with Inlybest 5mg tablet because it may cause harm to the baby. Please consult your doctor before breastfeeding.  

Lungs  

It is not known whether Inlybest 5mg tablet can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.  

Liver  

Inform your doctor if you have any liver problems before taking Inlybest 5mg tablet. Regular monitoring of liver function tests is recommended.  

Alcohol  

Consuming alcohol may affect the effectiveness of Inlybest 5mg tablet. Stop consuming alcohol if you are taking this medicine.  

Driving  

It is unsafe to drive vehicles or operate heavy machinery after taking Inlybest 5mg tablets, it may cause dizziness and impair your concentration.

Side Effects

• Extreme tiredness and swelling
• Pressure or pain in the chest, arms, back, neck or jaw
• Breathlessness
• Numbness and weakness on one side of the body
• Difficulty speaking or communicating verbally
• Headache
• Vision changes or dizziness
• Serious bleeding problems like black tarry stools, bloody cough or bloody sputum
• Severe stomach pain
• High blood pressure

• Kidney problems
• Dehydration
• Hyper-active thyroid gland
• Sore throat
• Loss of appetite
• Joint pain
• Lack of energy
• Weight loss
• Constipation
• Mouth sores
• Skin itching, redness of skin and hair loss

Strength	5 mg
Composition	Axitinib
Pack Size	14 Tablets
Brand	Axitinib Hetero
Form	Tablet
Usage	RCC
Storage Condition	Store below 30 DegreeC
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Kytib 5mg tablet is an anticancer drug belonging to the class of tyrosine kinase inhibitors, containing the active ingredient Axitinib. It is used to treat advanced kidney cancer which is also known as renal cell carcinoma that originates in the cells of the kidney.

It is not recommended to undergo surgical procedures while on treatment with this drug due to the high risk of bleeding. Tell your physician before you undergo surgery or dental procedures. Get immediate medical attention if you experience itching, vision changes, confusion, or dizziness. This medicine may cause harm to an unborn baby. Tell your healthcare provider before beginning this treatment if you are pregnant or planning to have a baby. It is advised for both men and women to follow proper contraceptive methods during and one week after the last dose of this drug. Avoid breastfeeding your baby while you are on the treatment as this drug can impact the growth and development of the baby by passing into the breast milk. If you get mouth sores, weight loss, and have itchy skin, consult with your doctor.

This drug is not recommended for adolescents and children under the age of 18. Contact your doctor immediately if you experience shortness of breath, chest pain, or worsening cough. During the treatment, your doctor may periodically monitor your white blood cell counts, platelets, blood sugar, electrolytes, and kidney parameters to prevent serious complications. Some GI symptoms may also develop during the treatment such as diarrhea, nausea, vomiting, and constipation. It is necessary to report to your doctor right away.

Uses of Kytib 5mg Tablet

• Advanced kidney cancer

 

More Information

• Store Kytib 5mg tablet in the original package at room temperature (20°C to 25°C).
• Keep it out of reach from children.

Safety Advices   Pregnancy  

Kytib 5mg tablet is not recommended for pregnant women as it may cause fetal harm. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.  

Breast Feeding  

It is unsafe to breastfeed during the treatment with Kytib 5mg tablet because it may cause harm to the baby. Please consult your doctor before breastfeeding.  

Lungs  

It is not known whether Kytib 5mg tablet can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.  

Liver  

Inform your doctor if you have any liver problems before taking Kytib 5mg tablet. Regular monitoring of liver function tests is recommended.  

Alcohol  

Consuming alcohol may affect the effectiveness of Kytib 5mg tablet. Stop consuming alcohol if you are taking this medicine.  

Driving  

It is unsafe to drive vehicles or operate heavy machinery after taking Kytib 5mg tablets, it may cause dizziness and impair your concentration.

Side Effects

• Extreme tiredness and swelling
• Pressure or pain in the chest, arms, back, neck or jaw
• Breathlessness
• Numbness and weakness on one side of the body
• Difficulty speaking or communicating verbally
• Headache
• Vision changes or dizziness
• Serious bleeding problems like black tarry stools, bloody cough or bloody sputum
• Severe stomach pain
• High blood pressure

• Kidney problems
• Dehydration
• Hyper-active thyroid gland
• Sore throat
• Loss of appetite
• Joint pain
• Lack of energy
• Weight loss
• Constipation
• Mouth sores
• Skin itching, redness of skin and hair loss

Strength	200 mg
Brand	Xperza
Packaging Size	14 Tablets
Dose Type	Oral
Form	Tablet
Indication	AML
Storage Condition	Store below 30 DegreeC
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Xpreza 200mg Tablet for Tablet is used for treating adults with Myelodysplastic syndrome (MDS) and Acute myeloid leukemia (AML) if they are considered ineligible for stem cell transplant. In Myelodysplastic Syndrome, the bone marrow does not produce healthy blood cells due to its lack of function. Acute Myeloid Leukemia is a type of bone marrow cancer that is caused by the release of incompletely formed blood cells into the bloodstream.

Uses of Xpreza 200mg Tablet

• Treatment of Acute Myeloid Leukemia with 20-30% blasts in patients who are not eligible for Haemopoietic stem cell transplant
• Intermediate-2 and High-risk Myelodysplastic syndrome (MDS)

Therapeutic Effects of Xpreza 200mg Tablet

In MDS and AML, the development of tumor cells is caused by the process of transcriptional repression of various genes, which is due to the hypermethylation of DNA. Transcriptional repression is a process where proteins bind directly or indirectly to DNA and control the activity of copying a specific gene or a set of genes. The active form of Xpreza 200mgTablet binds to RNA and DNA, interrupts their activity in actively multiplying cells, and exhibits a toxic effect on cancer cells.

Interaction of Xpreza 200mg Tablet with other drugs

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Xpreza 200mg Tablet and cause undesirable side effects. 

More Information about Xpreza 200mg Tablet

Store at room temperature (15-30°C). If the product is reconstituted, it must be used immediately; if not, store at 2-8°C for not more than 8 hours. Keep the Tablet out of sight and reach of children.

Safety Advices Pregnancy  

Xpreza 200mg Tablet could be harmful to the unborn fetus. Inform your physician if you are pregnant or planning to get pregnant.   

Breast Feeding  

Breastfeeding is not intended for patients on Xpreza 200mg Tablet therapy. Consult your physician for advice.  

Lungs  

It is not known whether it is safe to administer Xpreza 200mg Tablet in lung failure patients. Please consult your doctor.  

Liver  

Inform your physician if you have been told that you have a tumor in the liver cells.  

Alcohol  

It is not known whether it is safe to consume alcohol with Xpreza 200mg Tablet. Please consult your doctor.  

Driving  

It is unsafe to drive after taking this Tablet as it causes dizziness and patients lack concentration and alertness. So, avoid driving and handling heavy machinery after taking Xpreza 200mg Tablet.

Side Effects

• Unexpected bleeding, with blood in stool and urine
• Fever
• Pneumonia, is characterized by chest pain or breathlessness.
• Allergic reaction with symptoms of swelling of lips, itching, or rashes.
• Seizures, loss of consciousness, severe headache, or bleeding in the brain
• Frequent urination with pain or burning sensation

• Disturbances in the blood count (RBC, WBC, Platelets)
• Nausea, vomiting, diarrhea
• Constipation
• Tiredness
• Skin reactions like redness and pain at the site of Tablet
• Decreased appetite
• Dizziness
• Pain in extremities
• Joint pain
• Stomach pain
• Headache
• Sore nose and throat
• Rashes and bruising

Formulation Type	Nanoparticle Albumin-Bound
Brand	BD-Taxel
Pharmacopoeia Standard	IP
Pack Type	Vial
Packaging Size	16.7 ml
Shelf Life	24 months
Strength	300 mg
Packaging Type	Vial
Brand Name	BD Taxel
Manufacturer	BDR Pharmaceuticals Internationals Pvt
Usages	Used for the treatment of breast cancer, pancreatic cancer and non-small cell lung cancer.
Country of Origin	Made in India

BD Taxel 300 mg Injection is an anticancer medicine. It treats breast cancer, non-small cell lung cancer, ovarian cancer, and AIDS (Acquired Immuno-Deficiency Syndrome). Cancer is a condition in which cells are dividing and growing fast and in an uncontrolled manner. This Injection may be given alone or in combination with other anticancer medicines. It should not be used for severe liver problems, uncontrolled infection, and low white blood cell or platelet count. 

This medicine is not recommended for adolescents and children under the age of 18. Talk to your doctor if you have heart disorders before taking this medicine. Administration of this medicine can cause serious allergic reactions. Use effective birth control during the treatment and for at least six months after the last dose. This Injection may harm patients suffering from alcoholism as this medicine contains alcohol.

Uses of Bd Taxel 300mg Injection

• Ovarian cancer
• Breast cancer
• Non-small cell lung cancer
• AIDS-related Kaposi’s sarcoma

Therapeutic Effects of Bd Taxel 300mg Injection

BD Taxel 300 mg Injection binds to β-tubulin subunits of microtubules, interferes with interphase (a process involving cell growth) and mitotic functions (a process of cell division), and prevents the growth of cancer cells.

Interaction of Bd Taxel 300mg Injection with other drugs

Inform your doctor about any prescribed medicines, over-the-counter medications, nutritional and vitamin supplements, or herbal products that you are taking or have taken before the treatment. Certain medications may interact with BD Taxel 300 mg injection and cause undesirable side effects.

More Information about Bd Taxel 300mg Injection

• Keep BD Taxel 300 mg Injection out of sight and reach of children.
• Do not store above 25°C.

How to consume Bd Taxel 300mg Injection

It will be given to you by a doctor or nurse. Do not self-administer. Your doctor will decide the dose and dosage of the BD Taxel 300 mg injection.

Safety Advices  Pregnancy  

BD Taxel 300 mg Injection can harm your unborn baby. Tell your doctor if you are pregnant or planning to get pregnant before taking this Injection.   

Breast Feeding  

Stop breastfeeding during the treatment with BD Taxel 300 mg Injection. Consult your doctor for potential risks.  

Lungs  

It is unknown whether BD Taxel 300 mg injection can be given to patients with lung disorders. Please consult your physician for more advice.  

Liver  

It is contraindicated in patients with severe liver disorders. Inform your doctor if you have any liver disorders before taking BD Taxel 300 mg Injection.  

Alcohol  

It is unsafe to consume alcohol with BD Taxel 300 mg Injection.  

Driving  

The alcohol present in BD Taxel 300 mg Injection may affect your ability to drive. Avoid driving if you feel unwell.

Side Effects

• Serious allergic reactions (rash, swelling of face, lips, throat, or tongue, trouble breathing, and swallowing)
• Severe diarrhea
• Severe stomach pain

• Anemia, feeling tired
• Hair loss
• Burning, tingling, or numbness in your feet or hands
• Muscle and joint pain
• Vomiting, nausea
• Mouth or lip sores
• Infections
• Swelling of hands, feet, and face
• Bleeding
• Irritation at the injection site
• Low blood pressure

Strength	3.75 mg
Brand	Bdrelin
Dosage Form	Lyophilized Powder
Packaging Type	Vial
Composition	Triptorelin Acetate
Packaging Size	1 Vial + 1 Ampoule
Route of Administration	IM
Prescription/Non Prescription	Prescription
Manufacturer	BDR Pharmaceuticals Internationals Pvt
Country of Origin	Made in India

Bdrelin 3.75mg injection contains an active component as Triptorelin.  It is a medication that belongs to a class of drugs known as gonadotropin-releasing hormone (GnRH) analogs. It is primarily used in the field of reproductive medicine for the treatment of various conditions related to hormonal imbalance. One of the most common use is in treating certain hormone-dependent conditions such as prostate cancer, breast cancer, and endometriosis. In prostate cancer, for example, this medication is used to lower the levels of testosterone, which can help slow down the growth of cancer cells.

Uses

• Prostate cancer in men
• Early onset puberty in children 2 years of age and older (precocious puberty)

More Information

• Store at room temperature, between 20°C to 25°C (68°F to 77°F).
• Keep away from moisture, heat, and light.
• It should not be frozen.
• Keep away from children and pets.

Safety Advices   Pregnancy  

Bdrelin 3.75mg injection is generally not recommended for use during pregnancy. If pregnancy is planned or suspected while using this medication, it is important to inform the healthcare professional promptly. They can provide appropriate guidance and make necessary adjustments to the treatment plan.   

Breast Feeding  

The safety of Bdrelin 3.75mg injection during breastfeeding is not well established. It is advisable to avoid using it while breastfeeding unless the potential benefits outweigh the potential risks to the nursing infant.  

Lungs  

Bdrelin 3.75mg injection is generally considered safe for use in individuals with lung conditions. However, as with any medication, it is important to consult with a healthcare professional before starting this medication if you have a lung condition or any respiratory issues.  

Liver  

Bdrelin 3.75mg injection should be used with caution in individuals with liver impairment or liver disease. The metabolism and elimination of this medication may be affected in such cases. However, there is limited information available specifically regarding the safety in patients with liver conditions.  

Alcohol  

The use of Bdrelin 3.75mg injection in combination with alcohol is not well studied, and there is limited information available specifically regarding the interaction between this medication and alcohol. Therefore, it is generally recommended to exercise caution and avoid excessive alcohol consumption while using it.  

Driving  

Common side effects of Bdrelin 3.75mg injection may include hot flashes, mood changes, and fatigue. If any of these side effects occur and significantly impact your alertness, concentration, or motor skills, it is advisable to avoid driving or operating machinery until you feel capable of doing so safely.

Side Effects

• Swallowing or breathing trouble
• Increased lymphocyte count in the blood
• Swelling of lips, tongue or throat

• Hot flushes
• Weakness
• Excessive sweating
• Back pain
• Impotence
• Nausea
• Dry mouth
• Pain, bruising, redness at the injection site
• High blood pressure
• Weight gain
• Dizziness
• Headache

Treatment Type	Breast Cancer
Strength	3.75 mg
Packaging Size	1 units
Generic Name	Triptorelin Acetate
Packaging Type	Vial
Administration Route	Subcutaneous
Composition	Triptorelin Acetate
Frequency Of Administration	Monthly
Treatment	Prostate Cancer
Dosage Form	Injection
Manufacturer	Ferring
Brand	Decapeptyl
Country of Origin	Made in India

Decapeptyl Depot 3.75mg injection contains an active component as Triptorelin.  It is a medication that belongs to a class of drugs known as gonadotropin-releasing hormone (GnRH) analogs. It is primarily used in the field of reproductive medicine for the treatment of various conditions related to hormonal imbalance. One of the most common use is in treating certain hormone-dependent conditions such as prostate cancer, breast cancer, and endometriosis. In prostate cancer, for example, this medication is used to lower the levels of testosterone, which can help slow down the growth of cancer cells.Uses Prostate cancer in menEarly onset puberty in children 2 years of age and older (precocious puberty)More Information Store at room temperature, between 20°C to 25°C (68°F to 77°F).Keep away from moisture, heat, and light.It should not be frozen.Keep away from children and pets.  Safety Advices PregnancyDecapeptyl Depot 3.75mg injection is generally not recommended for use during pregnancy. If pregnancy is planned or suspected while using this medication, it is important to inform the healthcare professional promptly. They can provide appropriate guidance and make necessary adjustments to the treatment plan.   Breast FeedingThe safety of Decapeptyl Depot 3.75mg injection during breastfeeding is not well established. It is advisable to avoid using it while breastfeeding unless the potential benefits outweigh the potential risks to the nursing infant.  LungsDecapeptyl Depot 3.75mg injection is generally considered safe for use in individuals with lung conditions. However, as with any medication, it is important to consult with a healthcare professional before starting this medication if you have a lung condition or any respiratory issues.  LiverDecapeptyl Depot 3.75mg injection should be used with caution in individuals with liver impairment or liver disease. The metabolism and elimination of this medication may be affected in such cases. However, there is limited information available specifically regarding the safety in patients with liver conditions.  AlcoholThe use of Decapeptyl Depot 3.75mg injection in combination with alcohol is not well studied, and there is limited information available specifically regarding the interaction between this medication and alcohol. Therefore, it is generally recommended to exercise caution and avoid excessive alcohol consumption while using it.  DrivingCommon side effects of Decapeptyl Depot 3.75mg injection may include hot flashes, mood changes, and fatigue. If any of these side effects occur and significantly impact your alertness, concentration, or motor skills, it is advisable to avoid driving or operating machinery until you feel capable of doing so safely.Side Effects Swallowing or breathing troubleIncreased lymphocyte count in the bloodSwelling of lips, tongue or throatHot flushesWeaknessExcessive sweatingBack painImpotenceNauseaDry mouthPain, bruising, redness at the injection siteHigh blood pressureWeight gainDizzinessHeadache

Strength	3.75 mg
Formulation Type	Depot
Composition	Leuprolide Acetate
Packaging Type	Vial
Manufacturer	Bharat Serum
Packaging Size	1 x 1
Storage Temperature	2-8 degree c
Country of Origin	Made in India

Luprodex 3.75mg injection consists of the active ingredient Leuprolide acetate. It belongs to the class of medicines called Gonadotropin Releasing Hormone (GnRH) agonists. This injection treats prostate cancer in men, hormone-responsive breast cancer, endometriosis (tissue that usually lines the interior of the uterus grows outside of it), and uterine fibroids (noncancerous growths of the uterus) in women. This medicine is also used for the treatment of premature puberty, which is characterized by early physical development in children due to hormonal imbalances.Do not receive this injection if you are allergic to Luprodex 3.75mg or its ingredients, including Goserelin and Triptorlin. Before receiving this medicine, inform your physician if you have a liver or kidney impairment. Inform your doctor if you have undiagnosed abnormal uterine bleeding. Do not take this treatment if you are pregnant or planning to get pregnant. During the treatment, the existing symptoms may worsen due to the sex steroid increase in the body. Talk to your physician for more concerns. Report to your doctor if your child has a progressive brain tumor. Uses Prostate cancerHormone-responsive breast cancer in perimenopausal (around menopause) womenEndometriosis (a painful illness in which the tissue that normally lines the inside of the uterus grows outside of your uterus)Central precocious puberty (a child’s body begins to change into an adult too soon caused by a release of certain hormones)More Information Keep Luprodex 3.75mg out of sight and reach of children.Store in a cool, dry place, away from direct heat and light.Store below 25°CDo not refrigerate or freeze.Safety Advices  Pregnancy  It is unsafe to use Luprodex 3.75mg injection because it is contraindicated in pregnant women. Tell your doctor if you are pregnant or planning to get pregnant before taking this treatment.   Breast Feeding  Luprodex 3.75mg injection is contraindicated in breastfeeding women. Inform your doctor if you are breastfeeding before taking this injection.  Lungs  It is unknown whether Luprodex 3.75mg is safe for patients with lung problems. Notify your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.  Liver  Luprodex 3.75mg should be used cautiously in patients with liver impairment. Consult your doctor before receiving it. Notify your doctor about underlying liver conditions.   Alcohol  Consuming alcohol during the Luprodex 3.75mg injection treatment may increase the risk of thinning bones (osteoporosis). Hence caution should be taken. Consult your doctor for more information.  Driving  Luprodex 3.75mg Injection can cause drowsiness, visual disturbances, or dizziness. It is unsafe; hence avoid driving if you are unwell.Side Effects Severe rash, itchingShortness or difficulty of breathCough with bloodPulmonary embolismSevere headacheAltered blood sugar and cholesterol levelsInjection site reactionsLoss of appetiteAbnormal liver functionSwelling in the ankle or handDifficulty sleeping, headacheMood swings, depressionWeight changesNausea, vomitingVaginal dryness, bleedingLoss of interest in sexual intercourseHot flushesBone pain, muscle weaknessBreast tenderness

Strength	1 g
Dose/Strength	1000 mg
Injection Type	Lyophilized Powder
Composition	Gemcitabine
Packaging Size	Vial
Brand	Gemget
Route	IV
Packaging Type	Vial
Storage Condition	Store at 30 degree Celsius
Prescription/Non prescription	Prescription
Manufacturer	GLS Pharma Ltd.
Form	Injection
Shelf Life	24 Months
Usage/Application	Hospital
Country of Origin	Made in India

Gemget 1gm injection is a chemotherapy medication containing the active ingredient gemcitabine. It is used to treat bladder cancer, breast cancer, ovarian cancer, pancreatic cancer, and non-small cell lung cancer. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. Talk to your doctor if you have heart disease, liver disorders, kidney disorders, recently had radiotherapy, or vaccinated before taking this medicine. 

Gemget 1gm injection is not recommended for adolescents and children under the age of 18. Your doctor will assess your blood cell counts and kidney and liver function each time you are given this medicine. Use effective birth control during the treatment and at least six months after the last dose. This injection may impair fertility in male patients. Men taking this medicine are advised not to father a child during the treatment and for 6 months after the treatment. 

Tell your physician if you are on a salt-controlled diet, as this medicine contains sodium. Report to your doctor immediately if you experience shortness of breath, wheezing, changes in color or volume of urine, bleeding, or upper abdominal pain while taking Gemget 1gm injection.

Uses of Gemget 1gm Injection

Gemget 1gm injection is used to treat

• Bladder cancer, in combination with cisplatin
• Ovarian cancer, in combination with carboplatin
• Breast cancer, in combination with paclitaxel
• Pancreatic cancer
• Non-small cell lung cancer (NSCLC), alone or in combination with cisplatin

More Information

• Keep Gemget 1gm injection out of sight and reach of children.
• This medicine does not require any special storage conditions.
• Do not refrigerate or freeze.

Safety Advices Pregnancy  

Gemget 1gm injection can cause harm to your unborn baby. Tell your doctor if you are pregnant or planning to get pregnant before taking this treatment.   

Breast Feeding  

You must not breastfeed while being treated with Gemget 1gm injection. Inform your doctor if you are breastfeeding before taking this injection.  

Lungs  

Gemget 1gm injection is used cautiously in a patient with a lung disorder. Inform your doctor if you have any lung disease.   

Liver  

You need to tell your doctor if you have any liver disorders before taking Gemget 1gm injection. Your doctor may decide to adjust the dose or delay treating you depending on your liver function.  

Alcohol  

It is not advised to take alcohol while under this treatment because Gemget 1gm may cause drowsiness and sleepiness.  Talk to your doctor for more information.  

Driving  

Gemget 1gm injection could affect your ability to drive. Avoid driving while taking this medicine. Talk to your doctor for more information. 

Side Effects

• Pulmonary toxicity (shortness of breath, wheezing, cough)
• Hemolytic-uremic syndrome (Changes in the volume or colour of urine, increased bruising, or bleeding)
• Pain or tenderness in the upper abdomen
• Allergic reactions, rashes, fever, swelling or sores in the mouth

• Nausea, vomiting
• Low blood cell count
• Loss of appetite
• Hair loss
• Swelling of ankles, feet, and fingers
• Insomnia
• Constipation, diarrhea
• Headache
• Runny nose, chills
• Muscle pain, back pain
• Sweating
• hair loss
• liver problems
• blood in urine
• abnormal urine test
• Oedema (swelling of ankles, fingers, feet, face)

Strength	1 g
Dose/Strength	1000 mg
Injection Type	Lyophilized Powder
Composition	Gemcitabine
Packaging Size	Vial
Brand	Tabicad
Route	IV
Packaging Type	Vial
Storage Condition	Store at 30 degree Celsius
Manufacturer	Cadila Pharmaceuticals Ltd
Prescription/Non prescription	Prescription
Form	Injection
Shelf Life	24 Months
Usage/Application	Hospital
Country of Origin	Made in India

Tabicad 1gm injection is a chemotherapy medication containing the active ingredient gemcitabine. It is used to treat bladder cancer, breast cancer, ovarian cancer, pancreatic cancer, and non-small cell lung cancer. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. Talk to your doctor if you have heart disease, liver disorders, kidney disorders, recently had radiotherapy, or vaccinated before taking this medicine. 

Tabicad 1gm injection is not recommended for adolescents and children under the age of 18. Your doctor will assess your blood cell counts and kidney and liver function each time you are given this medicine. Use effective birth control during the treatment and at least six months after the last dose. This injection may impair fertility in male patients. Men taking this medicine are advised not to father a child during the treatment and for 6 months after the treatment. 

Tell your physician if you are on a salt-controlled diet, as this medicine contains sodium. Report to your doctor immediately if you experience shortness of breath, wheezing, changes in color or volume of urine, bleeding, or upper abdominal pain while taking Tabicad 1gm injection.

Uses

Tabicad 1gm injection is used to treat

• Bladder cancer, in combination with cisplatin
• Ovarian cancer, in combination with carboplatin
• Breast cancer, in combination with paclitaxel
• Pancreatic cancer
• Non-small cell lung cancer (NSCLC), alone or in combination with cisplatin

More Information

• Keep Tabicad 1gm injection out of sight and reach of children.
• This medicine does not require any special storage conditions.
• Do not refrigerate or freeze.

Safety Advices   Pregnancy  

Tabicad 1gm injection can cause harm to your unborn baby. Tell your doctor if you are pregnant or planning to get pregnant before taking this treatment.   

Breast Feeding  

You must not breastfeed while being treated with Tabicad 1gm injection. Inform your doctor if you are breastfeeding before taking this injection.  

Lungs  

Tabicad 1gm injection is used cautiously in a patient with a lung disorder. Inform your doctor if you have any lung disease.   

Liver  

You need to tell your doctor if you have any liver disorders before taking Tabicad 1gm injection. Your doctor may decide to adjust the dose or delay treating you depending on your liver function.  

Alcohol  

It is not advised to take alcohol while under this treatment because Tabicad 1gm may cause drowsiness and sleepiness.  Talk to your doctor for more information.   

Driving  

Tabicad 1gm injection could affect your ability to drive. Avoid driving while taking this medicine. Talk to your doctor for more information. 

Side Effects

• Pulmonary toxicity (shortness of breath, wheezing, cough)
• Hemolytic-uremic syndrome (Changes in the volume or colour of urine, increased bruising, or bleeding)
• Pain or tenderness in the upper abdomen
• Allergic reactions, rashes, fever, swelling or sores in the mouth

• Nausea, vomiting
• Low blood cell count
• Loss of appetite
• Hair loss
• Swelling of ankles, feet, and fingers
• Insomnia
• Constipation, diarrhea
• Headache
• Runny nose, chills
• Muscle pain, back pain
• Sweating
• hair loss
• liver problems
• blood in urine
• abnormal urine test
• Oedema (swelling of ankles, fingers, feet, face)

Strength	80 mg
Brand	Tagrisso
Tablets per Pack	10 Tablets
Usage	Lung Cancer, Cancer Care
Form	Tablet
Pack Type	Strip
Manufacturer	ASTRAZENECA

Tagrisso 80mg tablet contains the active substance Osimertinib. It is an antineoplastic drug that belongs to the class of protein kinase inhibitors. tagrisso used to treat adults with a type of lung cancer called non-small cell lung cancer. If a test has shown that your cancer has certain changes in a gene called EGFR (epidermal growth factor receptor), then your cancer will likely respond to treatment with this medicine. 
Tagrisso 80mg tablet can be given to you after the complete removal of your cancer as a post-surgical adjuvant treatment. It can also be given as the first-line medication for cancer that has spread to other body parts. It is also used to treat certain types of NSCLC that have spread to other body parts in adults who could not be treated successfully with similar chemotherapy medications. Do not give this medicine to children or adolescents under the age of 18.
Do not take Tagrisso tab 80mg if you are allergic to Osimertinib or any other ingredients of this medicine. Before initiating the treatment, inform your physician if you have kidney, heart, or eye problems and if you have suffered from lung inflammation. Report any symptoms of difficulty breathing together with a cough or fever, severe peeling of your skin, persistent fever, bleeding or bruising more easily, increased tiredness, pale skin, and infection.

Uses
Certain types of non-small cell lung cancer (NSCLC)

Side Effects 
Low WBC and plateletsDiarrhea, decreased appetiteAnemiaRashMuscle and joint painNail changesDry skinTirednessCoughInflamed and sore mouth Decreased heart function, irregular heartbeatsBreathing difficulty together with a cough or feverEye problemsAnemiaSkin lesions

Strength	25 mg
Packaging Size	30 Tablets
Brand	Xtane
Composition	Exemestane
Dosage Form	Tablet
Form	Tablet
Prescription	Prescription
Storage Condition	Store below 30 DegreeC
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Xtane 25mg tablet is an anticancer drug with the active ingredient Exemestane. It belongs to the medication class known as aromatase inhibitors. In postmenopausal women, it is used to treat hormone-dependent early breast cancer after completing 2-3 years of treatment with Tamoxifen. In addition, it also treats hormone-dependent advanced breast cancer.  Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. Do not take this medicine if you are allergic to Exemestane or any of the other ingredients of this medicine and if you have not been through the menopause stage, also if you think you are pregnant or breastfeeding. 

Xtane 25mg tablet is not recommended for adolescents and children under the age of 18. Inform your doctor before starting the treatment, if you have problems with your liver or kidney or if you have a history of the bone condition as this medicine can make you lose mineral content and decrease its strength. Inform your doctor if you take any other medicine while under this treatment. Regular checking will be conducted to monitor the vitamin D level, if your level is below normal you will be given vitamin D.  You need to tell your doctor about all the medications you are taking recently before taking this medicine. Use effective birth control during the treatment with this medicine. 

Uses of Xtane 25mg Tablet

• Breast cancer

Therapeutic Effects of Xtane 25mg Tablet

Xtane 25mg inhibits the enzyme aromatase, which is responsible for the conversion of androgens (male hormones) to estrogen (female hormones). By inhibiting aromatase, Xtane 25mg reduces the levels of estrogen in the body. This can stop or reduce the growth of different hormone-sensitive breast cancer cells, which depends on estrogen. 

More Information

• Keep the tablets away from light and moisture.
• Keep the tablets out of the reach of children and animals.
• This medicine does not require any special storage conditions.

Safety Advices Pregnancy  

Do not take this Xtane 25mg if you are pregnant because it may cause harm to the unborn baby. Consult your doctor before starting the treatment.   

Breast Feeding  

It is unsafe to breastfeed while taking Xtane 25mg because it can cause toxicity to the baby. Please consult your physician for more advice.  

Lungs  

It is unknown if patients with lung conditions can consume Xtane 25mg. So, before beginning the treatment, consult your doctor if you have any lung conditions.  

Liver  

Inform your physician about any underlying liver disorders before taking Xtane 25mg, as this medication should be used with caution in liver disease patients.  

Alcohol  

It is unknown if drinking alcohol while taking an Xtane 25mg tablet is safe. Please speak with your physician.  

Driving  

Xtane 25mg may affect the ability to drive in some patients. Hence, it is advised to avoid driving if you feel tired or weak while taking this injection.

Side Effects

• Lowered white blood cell (leukopenia)
• Reduction of platelets in the blood
• Allergic reaction
• Difficulty in breathing

• Numbness and hand pain (Carpal tunnel syndrome)
• Depression
• High levels of liver enzymes
• Diarrhea, Nausea
• Depression
• Joint and back pain
• Fatigue
• Abdomen pain
• Swelling in hands and feets
• Muscle pain
• Tingling, pain, coldness, weakness in parts of the hand

Strength	1 g
Dose/Strength	1000 mg
Injection Type	Lyophilized Powder
Composition	Gemcitabine
Packaging Size	Vial
Brand	Gembin
Route	IV
Packaging Type	Vial
Storage Condition	Store below 30 DegreeC
Manufacturer	Zydus Cadila
Prescription/Non prescription	Prescription
Form	Injection
Shelf Life	24 Months
Usage/Application	Personal
Country of Origin	Made in India

Gembin 1000mg injection is a chemotherapy medication containing the active ingredient gemcitabine. It is used to treat bladder cancer, breast cancer, ovarian cancer, pancreatic cancer, and non-small cell lung cancer. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. Talk to your doctor if you have heart disease, liver disorders, kidney disorders, recently had radiotherapy, or vaccinated before taking this medicine. 

Gembin 1000mg injection is not recommended for adolescents and children under the age of 18. Your doctor will assess your blood cell counts and kidney and liver function each time you are given this medicine. Use effective birth control during the treatment and at least six months after the last dose. This injection may impair fertility in male patients. Men taking this medicine are advised not to father a child during the treatment and for 6 months after the treatment. 

Tell your physician if you are on a salt-controlled diet, as this medicine contains sodium. Report to your doctor immediately if you experience shortness of breath, wheezing, changes in color or volume of urine, bleeding, or upper abdominal pain while taking Gembin 1000mg injection.

Uses of Gembin 1000mg Injection

Gembin 1000mg injection is used to treat

• Bladder cancer, in combination with cisplatin
• Ovarian cancer, in combination with carboplatin
• Breast cancer, in combination with paclitaxel
• Pancreatic cancer
• Non-small cell lung cancer (NSCLC), alone or in combination with cisplatin

 

More Information

• Keep Gembin 1000mg injection out of sight and reach of children.
• This medicine does not require any special storage conditions.
• Do not refrigerate or freeze.

Safety Advices Pregnancy  

Gembin 1000mg injection can cause harm to your unborn baby. Tell your doctor if you are pregnant or planning to get pregnant before taking this treatment.   

Breast Feeding  

You must not breastfeed while being treated with Gembin 1000mg injection. Inform your doctor if you are breastfeeding before taking this injection.  

Lungs  

Gembin 1000mg injection is used cautiously in a patient with a lung disorder. Inform your doctor if you have any lung disease.   

Liver  

You need to tell your doctor if you have any liver disorders before taking Gembin 1000mg injection. Your doctor may decide to adjust the dose or delay treating you depending on your liver function.  

Alcohol  

It is not advised to take alcohol while under this treatment because Gembin 1000mg may cause drowsiness and sleepiness.  Talk to your doctor for more information.  

Driving  

Gembin 1000mg injection could affect your ability to drive. Avoid driving while taking this medicine. Talk to your doctor for more information. 

Side Effects

• Pulmonary toxicity (shortness of breath, wheezing, cough)
• Hemolytic-uremic syndrome (Changes in the volume or colour of urine, increased bruising, or bleeding)
• Pain or tenderness in the upper abdomen
• Allergic reactions, rashes, fever, swelling or sores in the mouth

• Nausea, vomiting
• Low blood cell count
• Loss of appetite
• Hair loss
• Swelling of ankles, feet, and fingers
• Insomnia
• Constipation, diarrhea
• Headache
• Runny nose, chills
• Muscle pain, back pain
• Sweating
• hair loss
• liver problems
• blood in urine
• abnormal urine test
• Oedema (swelling of ankles, fingers, feet, face)

Dosage Form	Injection
Treatment	Myelodysplastic Syndrome
Manufacturer	Intas Pharmaceuticals
Packaging Type	Vial
Packaging Size	50 ml
Dose Strength	150 mg
Storage Condition	Store in Refrigerator (2 to 8 Degree C)
Strength	150 mg
Country of Origin	Made in India

Azadine 150mg Injection for injection is used for treating adults with Myelodysplastic syndrome (MDS) and Acute myeloid leukemia (AML) if they are considered ineligible for stem cell transplant. In Myelodysplastic Syndrome, the bone marrow does not produce healthy blood cells due to its lack of function. Acute Myeloid Leukemia is a type of bone marrow cancer that is caused by the release of incompletely formed blood cells into the bloodstream.

Uses of Azadine 150mg Injection

• Treatment of Acute Myeloid Leukemia with 20-30% blasts in patients who are not eligible for Haemopoietic stem cell transplant
• Intermediate-2 and High-risk Myelodysplastic syndrome (MDS)

Therapeutic Effects of Azadine 150mg Injection

In MDS and AML, the development of tumor cells is caused by the process of transcriptional repression of various genes, which is due to the hypermethylation of DNA. Transcriptional repression is a process where proteins bind directly or indirectly to DNA and control the activity of copying a specific gene or a set of genes. The active form of Azadine 150mgInjection binds to RNA and DNA, interrupts their activity in actively multiplying cells, and exhibits a toxic effect on cancer cells.

Interaction of Azadine 150mg Injection with other drugs

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Azadine 150mg injection and cause undesirable side effects. 

More Information

Store at room temperature (15-30°C). If the product is reconstituted, it must be used immediately; if not, store at 2-8°C for not more than 8 hours. Keep the injection out of sight and reach of children.

Safety Advices   Pregnancy  

Azadine 150mg Injection could be harmful to the unborn fetus. Inform your physician if you are pregnant or planning to get pregnant.  

Breast Feeding  

Breastfeeding is not intended for patients on Azadine 150mg Injection therapy. Consult your physician for advice.  

Lungs  

It is not known whether it is safe to administer Azadine 150mg Injection in lung failure patients. Please consult your doctor.  

Liver  

Inform your physician if you have been told that you have a tumor in the liver cells.  

Alcohol  

It is not known whether it is safe to consume alcohol with Azadine 150mg Injection. Please consult your doctor.  

Driving  

It is unsafe to drive after taking this injection as it causes dizziness and patients lack concentration and alertness. So, avoid driving and handling heavy machinery after taking Azadine 150mg injection.

Side Effects

• Unexpected bleeding, with blood in stool and urine
• Fever
• Pneumonia, is characterized by chest pain or breathlessness.
• Allergic reaction with symptoms of swelling of lips, itching, or rashes.
• Seizures, loss of consciousness, severe headache, or bleeding in the brain
• Frequent urination with pain or burning sensation

• Disturbances in the blood count (RBC, WBC, Platelets)
• Nausea, vomiting, diarrhea
• Constipation
• Tiredness
• Skin reactions like redness and pain at the site of injection
• Decreased appetite
• Dizziness
• Pain in extremities
• Joint pain
• Stomach pain
• Headache
• Sore nose and throat
• Rashes and bruising

Formulation Type	Nanoparticle Albumin-Bound
Brand	Taxeleon
Pharmacopoeia Standard	IP
Pack Type	Vial
Packaging Size	16.7 ml
Shelf Life	24 months
Strength	300 mg
Packaging Type	Vial
Brand Name	Taxeleon
Manufacturer	Neon Laboratories Ltd
Usages	Used for the treatment of breast cancer, pancreatic cancer and non-small cell lung cancer.
Country of Origin	Made in India

Taxeleon 300 mg Injection is an anticancer medicine. It treats breast cancer, non-small cell lung cancer, ovarian cancer, and AIDS (Acquired Immuno-Deficiency Syndrome). Cancer is a condition in which cells are dividing and growing fast and in an uncontrolled manner. This Injection may be given alone or in combination with other anticancer medicines. It should not be used for severe liver problems, uncontrolled infection, and low white blood cell or platelet count. 

This medicine is not recommended for adolescents and children under the age of 18. Talk to your doctor if you have heart disorders before taking this medicine. Administration of this medicine can cause serious allergic reactions. Use effective birth control during the treatment and for at least six months after the last dose. This Injection may harm patients suffering from alcoholism as this medicine contains alcohol.

Uses of Taxeleon 300mg Injection

• Ovarian cancer
• Breast cancer
• Non-small cell lung cancer
• AIDS-related Kaposi’s sarcoma

Therapeutic Effects of Taxeleon 300mg Injection

Taxeleon 300 mg Injection binds to β-tubulin subunits of microtubules, interferes with interphase (a process involving cell growth) and mitotic functions (a process of cell division), and prevents the growth of cancer cells.

Interaction of Taxeleon 300mg Injection with other drugs

Inform your doctor about any prescribed medicines, over-the-counter medications, nutritional and vitamin supplements, or herbal products that you are taking or have taken before the treatment. Certain medications may interact with Taxeleon 300 mg injection and cause undesirable side effects.

More Information about Taxeleon 300mg Injection

• Keep Taxeleon 300 mg Injection out of sight and reach of children.
• Do not store above 25°C.

How to consume Taxeleon 300mg Injection

It will be given to you by a doctor or nurse. Do not self-administer. Your doctor will decide the dose and dosage of the Taxeleon 300 mg injection.

Safety Advices Pregnancy  

Taxeleon 300 mg Injection can harm your unborn baby. Tell your doctor if you are pregnant or planning to get pregnant before taking this Injection.   

Breast Feeding  

Stop breastfeeding during the treatment with Taxeleon 300 mg Injection. Consult your doctor for potential risks.  

Lungs  

It is unknown whether Taxeleon 300 mg injection can be given to patients with lung disorders. Please consult your physician for more advice.  

Liver  

It is contraindicated in patients with severe liver disorders. Inform your doctor if you have any liver disorders before taking Taxeleon 300 mg Injection.  

Alcohol  

It is unsafe to consume alcohol with Taxeleon 300 mg Injection.  

Driving  

The alcohol present in Taxeleon 300 mg Injection may affect your ability to drive. Avoid driving if you feel unwell.

Side Effects

• Serious allergic reactions (rash, swelling of face, lips, throat, or tongue, trouble breathing, and swallowing)
• Severe diarrhea
• Severe stomach pain

• Anemia, feeling tired
• Hair loss
• Burning, tingling, or numbness in your feet or hands
• Muscle and joint pain
• Vomiting, nausea
• Mouth or lip sores
• Infections
• Swelling of hands, feet, and face
• Bleeding
• Irritation at the injection site
• Low blood pressure

Formulation Type	Nanoparticle Albumin-Bound
Brand	Nanoxel
Pharmacopoeia Standard	IP
Pack Type	Vial
Packaging Size	16.7 ml
Shelf Life	24 months
Strength	300 mg
Packaging Type	Vial
Brand Name	Nanoxel
Manufacturer	FRESENIUS KABI INDIA PVT LTD
Usages	It treats breast cancer, non-small cell lung cancer, ovarian cancer, and AIDS (Acquired Immuno-Defic
Country of Origin	Made in India

Nanoxel 300 mg Injection is an anticancer medicine. It treats breast cancer, non-small cell lung cancer, ovarian cancer, and AIDS (Acquired Immuno-Deficiency Syndrome). Cancer is a condition in which cells are dividing and growing fast and in an uncontrolled manner. This Injection may be given alone or in combination with other anticancer medicines. It should not be used for severe liver problems, uncontrolled infection, and low white blood cell or platelet count. 

This medicine is not recommended for adolescents and children under the age of 18. Talk to your doctor if you have heart disorders before taking this medicine. Administration of this medicine can cause serious allergic reactions. Use effective birth control during the treatment and for at least six months after the last dose. This Injection may harm patients suffering from alcoholism as this medicine contains alcohol.

Uses of Nanoxel 300mg Injection

• Ovarian cancer
• Breast cancer
• Non-small cell lung cancer
• AIDS-related Kaposi’s sarcoma

Therapeutic Effects of Nanoxel 300mg Injection

Nanoxel 300 mg Injection binds to β-tubulin subunits of microtubules, interferes with interphase (a process involving cell growth) and mitotic functions (a process of cell division), and prevents the growth of cancer cells.

Interaction of Nanoxel 300mg Injection with other drugs

Inform your doctor about any prescribed medicines, over-the-counter medications, nutritional and vitamin supplements, or herbal products that you are taking or have taken before the treatment. Certain medications may interact with Nanoxel 300 mg injection and cause undesirable side effects.

More Information about Nanoxel 300mg Injection

• Keep Nanoxel 300 mg Injection out of sight and reach of children.
• Do not store above 25°C.

How to consume Nanoxel 300mg Injection

It will be given to you by a doctor or nurse. Do not self-administer. Your doctor will decide the dose and dosage of the Nanoxel 300 mg injection.

Safety Advices  Pregnancy  

Nanoxel 300 mg Injection can harm your unborn baby. Tell your doctor if you are pregnant or planning to get pregnant before taking this Injection.   

Breast Feeding  

Stop breastfeeding during the treatment with Nanoxel 300 mg Injection. Consult your doctor for potential risks.  

Lungs  

It is unknown whether Nanoxel 300 mg injection can be given to patients with lung disorders. Please consult your physician for more advice.  

Liver  

It is contraindicated in patients with severe liver disorders. Inform your doctor if you have any liver disorders before taking Nanoxel 300 mg Injection.  

Alcohol  

It is unsafe to consume alcohol with Nanoxel 300 mg Injection.  

Driving  

The alcohol present in Nanoxel 300 mg Injection may affect your ability to drive. Avoid driving if you feel unwell.

Side Effects

• Serious allergic reactions (rash, swelling of face, lips, throat, or tongue, trouble breathing, and swallowing)
• Severe diarrhea
• Severe stomach pain

• Anemia, feeling tired
• Hair loss
• Burning, tingling, or numbness in your feet or hands
• Muscle and joint pain
• Vomiting, nausea
• Mouth or lip sores
• Infections
• Swelling of hands, feet, and face
• Bleeding
• Irritation at the injection site
• Low blood pressure

Formulation Type	Nanoparticle Albumin-Bound
Brand	Paclitex
Pharmacopoeia Standard	IP
Pack Type	Vial
Packaging Size	16.7 ml
Shelf Life	24 months
Strength	300 mg
Packaging Type	Vial
Brand Name	Celtax
Manufacturer	Celon Laboratories Ltd
Usages	Used for the treatment of breast cancer, pancreatic cancer and non-small cell lung cancer.
Country of Origin	Made in India

Celtax 300 mg Injection is an anticancer medicine. It treats breast cancer, non-small cell lung cancer, ovarian cancer, and AIDS (Acquired Immuno-Deficiency Syndrome). Cancer is a condition in which cells are dividing and growing fast and in an uncontrolled manner. This Injection may be given alone or in combination with other anticancer medicines. It should not be used for severe liver problems, uncontrolled infection, and low white blood cell or platelet count. 

This medicine is not recommended for adolescents and children under the age of 18. Talk to your doctor if you have heart disorders before taking this medicine. Administration of this medicine can cause serious allergic reactions. Use effective birth control during the treatment and for at least six months after the last dose. This Injection may harm patients suffering from alcoholism as this medicine contains alcohol.

Uses of Celtax 300mg Injection

• Ovarian cancer
• Breast cancer
• Non-small cell lung cancer
• AIDS-related Kaposi’s sarcoma

Therapeutic Effects of Celtax 300mg Injection

Celtax 300 mg Injection binds to β-tubulin subunits of microtubules, interferes with interphase (a process involving cell growth) and mitotic functions (a process of cell division), and prevents the growth of cancer cells.

Interaction of Celtax 300mg Injection with other drugs

Inform your doctor about any prescribed medicines, over-the-counter medications, nutritional and vitamin supplements, or herbal products that you are taking or have taken before the treatment. Certain medications may interact with Celtax 300 mg injection and cause undesirable side effects.

More Information about Celtax 300mg Injection

• Keep Celtax 300 mg Injection out of sight and reach of children.
• Do not store above 25°C.

How to consume Celtax 300mg Injection

It will be given to you by a doctor or nurse. Do not self-administer. Your doctor will decide the dose and dosage of the Celtax 300 mg injection.

Safety Advices  Pregnancy  

Celtax 300 mg Injection can harm your unborn baby. Tell your doctor if you are pregnant or planning to get pregnant before taking this Injection.   

Breast Feeding  

Stop breastfeeding during the treatment with Celtax 300 mg Injection. Consult your doctor for potential risks.  

Lungs  

It is unknown whether Celtax 300 mg injection can be given to patients with lung disorders. Please consult your physician for more advice.  

Liver  

It is contraindicated in patients with severe liver disorders. Inform your doctor if you have any liver disorders before taking Celtax 300 mg Injection.  

Alcohol  

It is unsafe to consume alcohol with Celtax 300 mg Injection.  

Driving  

The alcohol present in Celtax 300 mg Injection may affect your ability to drive. Avoid driving if you feel unwell.

Side Effects

• Serious allergic reactions (rash, swelling of face, lips, throat, or tongue, trouble breathing, and swallowing)
• Severe diarrhea
• Severe stomach pain

• Anemia, feeling tired
• Hair loss
• Burning, tingling, or numbness in your feet or hands
• Muscle and joint pain
• Vomiting, nausea
• Mouth or lip sores
• Infections
• Swelling of hands, feet, and face
• Bleeding
• Irritation at the injection site
• Low blood pressure

Strength	11.25 mg
Brand	Bdrelin
Dosage Form	Lyophilized Powder
Packaging Type	Vial
Composition	Triptorelin Acetate
Packaging Size	1 Vial + 1 Ampoule
Route of Administration	IM
Prescription/Non Prescription	Prescription
Manufacturer	BDR Pharmaceuticals Internationals Pvt
Country of Origin	Made in India

Bdrelin 11.25mg injection contains an active component as Triptorelin.  It is a medication that belongs to a class of drugs known as gonadotropin-releasing hormone (GnRH) analogs. It is primarily used in the field of reproductive medicine for the treatment of various conditions related to hormonal imbalance. One of the most common use is in treating certain hormone-dependent conditions such as prostate cancer, breast cancer, and endometriosis. In prostate cancer, for example, this medication is used to lower the levels of testosterone, which can help slow down the growth of cancer cells.

Uses

• Prostate cancer in men
• Early onset puberty in children 2 years of age and older (precocious puberty)

More Information

• Store at room temperature, between 20°C to 25°C (68°F to 77°F).
• Keep away from moisture, heat, and light.
• It should not be frozen.
• Keep away from children and pets.

Safety Advices Pregnancy  

Bdrelin 11.25mg injection is generally not recommended for use during pregnancy. If pregnancy is planned or suspected while using this medication, it is important to inform the healthcare professional promptly. They can provide appropriate guidance and make necessary adjustments to the treatment plan.   

Breast Feeding  

The safety of Bdrelin 11.25mg injection during breastfeeding is not well established. It is advisable to avoid using it while breastfeeding unless the potential benefits outweigh the potential risks to the nursing infant.  

Lungs  

Bdrelin 11.25mg injection is generally considered safe for use in individuals with lung conditions. However, as with any medication, it is important to consult with a healthcare professional before starting this medication if you have a lung condition or any respiratory issues.  

Liver  

Bdrelin 11.25mg injection should be used with caution in individuals with liver impairment or liver disease. The metabolism and elimination of this medication may be affected in such cases. However, there is limited information available specifically regarding the safety in patients with liver conditions.  

Alcohol  

The use of Bdrelin 11.25mg injection in combination with alcohol is not well studied, and there is limited information available specifically regarding the interaction between this medication and alcohol. Therefore, it is generally recommended to exercise caution and avoid excessive alcohol consumption while using it.  

Driving  

Common side effects of Bdrelin 11.25mg injection may include hot flashes, mood changes, and fatigue. If any of these side effects occur and significantly impact your alertness, concentration, or motor skills, it is advisable to avoid driving or operating machinery until you feel capable of doing so safely.

Side Effects

• Swallowing or breathing trouble
• Increased lymphocyte count in the blood
• Swelling of lips, tongue or throat

• Hot flushes
• Weakness
• Excessive sweating
• Back pain
• Impotence
• Nausea
• Dry mouth
• Pain, bruising, redness at the injection site
• High blood pressure
• Weight gain
• Dizziness
• Headache

Physical Form	Powder
Treatment Type	Breast Cancer
Manufacturer	Dr Reddys Laboratories
Packaging Size	1 Vial
Brand	Dr. Reddy's
Packaging Type	Vial
Dosage Form	Injection
Storage	2 to 8 Degree C
Shelf Life	24 Months
Strength	22.5 mg
Country of Origin	Made in India

Pamorelin 22.5mg injection contains an active component as Triptorelin.  It is a medication that belongs to a class of drugs known as gonadotropin-releasing hormone (GnRH) analogs. It is primarily used in the field of reproductive medicine for the treatment of various conditions related to hormonal imbalance. One of the most common use is in treating certain hormone-dependent conditions such as prostate cancer, breast cancer, and endometriosis. In prostate cancer, for example, this medication is used to lower the levels of testosterone, which can help slow down the growth of cancer cells.Uses Prostate cancer in menEarly onset puberty in children 2 years of age and older (precocious puberty)More Information Store at room temperature, between 20°C to 25°C (68°F to 77°F).Keep away from moisture, heat, and light.It should not be frozen.Keep away from children and pets.Safety Advices PregnancyPamorelin 22.5mg injection is generally not recommended for use during pregnancy. If pregnancy is planned or suspected while using this medication, it is important to inform the healthcare professional promptly. They can provide appropriate guidance and make necessary adjustments to the treatment plan.   Breast FeedingThe safety of Pamorelin 22.5mg injection during breastfeeding is not well established. It is advisable to avoid using it while breastfeeding unless the potential benefits outweigh the potential risks to the nursing infant.  LungsPamorelin 22.5mg injection is generally considered safe for use in individuals with lung conditions. However, as with any medication, it is important to consult with a healthcare professional before starting this medication if you have a lung condition or any respiratory issues.  LiverPamorelin 22.5mg injection should be used with caution in individuals with liver impairment or liver disease. The metabolism and elimination of this medication may be affected in such cases. However, there is limited information available specifically regarding the safety in patients with liver conditions.  AlcoholThe use of Pamorelin 22.5mg injection in combination with alcohol is not well studied, and there is limited information available specifically regarding the interaction between this medication and alcohol. Therefore, it is generally recommended to exercise caution and avoid excessive alcohol consumption while using it.  DrivingCommon side effects of Pamorelin 22.5mg injection may include hot flashes, mood changes, and fatigue. If any of these side effects occur and significantly impact your alertness, concentration, or motor skills, it is advisable to avoid driving or operating machinery until you feel capable of doing so safely.Side Effects Swallowing or breathing troubleIncreased lymphocyte count in the bloodSwelling of lips, tongue or throatHot flushesWeaknessExcessive sweatingBack painImpotenceNauseaDry mouthPain, bruising, redness at the injection siteHigh blood pressureWeight gainDizzinessHeadache

Strength	0.1 mg
Brand	Agotrig
Dosage Form	Pre-filled Syringe
Packaging Type	Box
Composition	Triptorelin Acetate
Packaging Size	1 PFS
Route of Administration	IM
Prescription/Non Prescription	Prescription
Manufacturer	BHARAT SERUMS & VACCINES LTD
Country of Origin	Made in India

Agotrig 0.1mg injection contains an active component as Triptorelin.  It is a medication that belongs to a class of drugs known as gonadotropin-releasing hormone (GnRH) analogs. It is primarily used in the field of reproductive medicine for the treatment of various conditions related to hormonal imbalance. One of the most common use is in treating certain hormone-dependent conditions such as prostate cancer, breast cancer, and endometriosis. In prostate cancer, for example, this medication is used to lower the levels of testosterone, which can help slow down the growth of cancer cells.

Agotrig 0.1mg injection should not be used in individuals who have a known hypersensitivity or allergic reaction to the medication or any of its components. The safety and effectiveness of this medication have not been established in children, so a healthcare professional will carefully consider and monitor its use in this population.

Uses

• Prostate cancer in men
• Early onset puberty in children 2 years of age and older (precocious puberty)

More Information

• Store at room temperature, between 20°C to 25°C (68°F to 77°F).
• Keep away from moisture, heat, and light.
• It should not be frozen.
• Keep away from children and pets.

Safety Advices Pregnancy  

Agotrig 0.1mg injection is generally not recommended for use during pregnancy. If pregnancy is planned or suspected while using this medication, it is important to inform the healthcare professional promptly. They can provide appropriate guidance and make necessary adjustments to the treatment plan.   

Breast Feeding  

The safety of Agotrig 0.1mg injection during breastfeeding is not well established. It is advisable to avoid using it while breastfeeding unless the potential benefits outweigh the potential risks to the nursing infant.  

Lungs  

Agotrig 0.1mg injection is generally considered safe for use in individuals with lung conditions. However, as with any medication, it is important to consult with a healthcare professional before starting this medication if you have a lung condition or any respiratory issues.  

Liver  

Agotrig 0.1mg injection should be used with caution in individuals with liver impairment or liver disease. The metabolism and elimination of this medication may be affected in such cases. However, there is limited information available specifically regarding the safety in patients with liver conditions.  

Alcohol  

The use of Agotrig 0.1mg injection in combination with alcohol is not well studied, and there is limited information available specifically regarding the interaction between this medication and alcohol. Therefore, it is generally recommended to exercise caution and avoid excessive alcohol consumption while using it.  

Driving

Common side effects of Agotrig 0.1mg injection may include hot flashes, mood changes, and fatigue. If any of these side effects occur and significantly impact your alertness, concentration, or motor skills, it is advisable to avoid driving or operating machinery until you feel capable of doing so safely.

Side Effects

• Swallowing or breathing trouble
• Increased lymphocyte count in the blood
• Swelling of lips, tongue or throat

• Hot flushes
• Weakness
• Excessive sweating
• Back pain
• Impotence
• Nausea
• Dry mouth
• Pain, bruising, redness at the injection site
• High blood pressure
• Weight gain
• Dizziness
• Headache

Strength	1 g
Dose/Strength	1000 mg
Injection Type	Lyophilized Powder
Composition	Gemcitabine
Packaging Size	Vial
Route	IV
Packaging Type	Vial
Storage Condition	Stored at controlled room temperature (30 DegreeC)
Prescription/Non prescription	Prescription
Manufacturer	Fresenius Kabi India Pvt Ltd
Form	Injection
Shelf Life	24 Months
Usage/Application	Hospital
Country of Origin	Made in India
Brand	Fresenius Kabi

Gemita 1gm injection is a chemotherapy medication containing the active ingredient gemcitabine. It is used to treat bladder cancer, breast cancer, ovarian cancer, pancreatic cancer, and non-small cell lung cancer. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. Talk to your doctor if you have heart disease, liver disorders, kidney disorders, recently had radiotherapy, or vaccinated before taking this medicine. 

Gemita 1gm injection is not recommended for adolescents and children under the age of 18. Your doctor will assess your blood cell counts and kidney and liver function each time you are given this medicine. Use effective birth control during the treatment and at least six months after the last dose. This injection may impair fertility in male patients. Men taking this medicine are advised not to father a child during the treatment and for 6 months after the treatment. 

Tell your physician if you are on a salt-controlled diet, as this medicine contains sodium. Report to your doctor immediately if you experience shortness of breath, wheezing, changes in color or volume of urine, bleeding, or upper abdominal pain while taking Gemita 1gm injection.

Uses of Gemita 1gm Injection

Gemita 1gm injection is used to treat

• Bladder cancer, in combination with cisplatin
• Ovarian cancer, in combination with carboplatin
• Breast cancer, in combination with paclitaxel
• Pancreatic cancer
• Non-small cell lung cancer (NSCLC), alone or in combination with cisplatin

More Information

• Keep Gemita 1gm injection out of sight and reach of children.
• This medicine does not require any special storage conditions.
• Do not refrigerate or freeze.

Safety Advices Pregnancy  

Gemita 1gm injection can cause harm to your unborn baby. Tell your doctor if you are pregnant or planning to get pregnant before taking this treatment.   

Breast Feeding  

You must not breastfeed while being treated with Gemita 1gm injection. Inform your doctor if you are breastfeeding before taking this injection.  

Lungs  

Gemita 1gm injection is used cautiously in a patient with a lung disorder. Inform your doctor if you have any lung disease.   

Liver  

You need to tell your doctor if you have any liver disorders before taking Gemita 1gm injection. Your doctor may decide to adjust the dose or delay treating you depending on your liver function.  

Alcohol  

It is not advised to take alcohol while under this treatment because Gemita 1gm may cause drowsiness and sleepiness.  Talk to your doctor for more information.  

Driving  

Gemita 1gm injection could affect your ability to drive. Avoid driving while taking this medicine. Talk to your doctor for more information. 

Side Effects

• Pulmonary toxicity (shortness of breath, wheezing, cough)
• Hemolytic-uremic syndrome (Changes in the volume or colour of urine, increased bruising, or bleeding)
• Pain or tenderness in the upper abdomen
• Allergic reactions, rashes, fever, swelling or sores in the mouth

• Nausea, vomiting
• Low blood cell count
• Loss of appetite
• Hair loss
• Swelling of ankles, feet, and fingers
• Insomnia
• Constipation, diarrhea
• Headache
• Runny nose, chills
• Muscle pain, back pain
• Sweating
• hair loss
• liver problems
• blood in urine
• abnormal urine test
• Oedema (swelling of ankles, fingers, feet, face)

Strength	1 g
Dose/Strength	1000 mg
Injection Type	Lyophilized Powder
Composition	Gemcitabine
Packaging Size	Vial
Brand	Gemtero
Route	IV
Packaging Type	Vial
Storage Condition	Store at 30 degree Celsius
Manufacturer	Hetero Healthcare Ltd
Prescription/Non prescription	Prescription
Form	Injection
Shelf Life	24 Months
Usage/Application	Hospital
Country of Origin	Made in India

Gemtero 1gm injection is a chemotherapy medication containing the active ingredient gemcitabine. It is used to treat bladder cancer, breast cancer, ovarian cancer, pancreatic cancer, and non-small cell lung cancer. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. Talk to your doctor if you have heart disease, liver disorders, kidney disorders, recently had radiotherapy, or vaccinated before taking this medicine. 

Gemtero 1gm injection is not recommended for adolescents and children under the age of 18. Your doctor will assess your blood cell counts and kidney and liver function each time you are given this medicine. Use effective birth control during the treatment and at least six months after the last dose. This injection may impair fertility in male patients. Men taking this medicine are advised not to father a child during the treatment and for 6 months after the treatment. 

Tell your physician if you are on a salt-controlled diet, as this medicine contains sodium. Report to your doctor immediately if you experience shortness of breath, wheezing, changes in color or volume of urine, bleeding, or upper abdominal pain while taking Gemtero 1gm injection.

Uses

Gemtero 1gm injection is used to treat

• Bladder cancer, in combination with cisplatin
• Ovarian cancer, in combination with carboplatin
• Breast cancer, in combination with paclitaxel
• Pancreatic cancer
• Non-small cell lung cancer (NSCLC), alone or in combination with cisplatin

More Information

• Keep Gemtero 1gm injection out of sight and reach of children.
• This medicine does not require any special storage conditions.
• Do not refrigerate or freeze.

Safety Advices Pregnancy  

Gemtero 1gm injection can cause harm to your unborn baby. Tell your doctor if you are pregnant or planning to get pregnant before taking this treatment.   

Breast Feeding  

You must not breastfeed while being treated with Gemtero 1gm injection. Inform your doctor if you are breastfeeding before taking this injection.  

Lungs  

Gemtero 1gm injection is used cautiously in a patient with a lung disorder. Inform your doctor if you have any lung disease.   

Liver  

You need to tell your doctor if you have any liver disorders before taking Gemtero 1gm injection. Your doctor may decide to adjust the dose or delay treating you depending on your liver function.  

Alcohol  

It is not advised to take alcohol while under this treatment because Gemtero 1gm may cause drowsiness and sleepiness.  Talk to your doctor for more information.  

Driving  

Gemtero 1gm injection could affect your ability to drive. Avoid driving while taking this medicine. Talk to your doctor for more information. 

Side Effects

• Pulmonary toxicity (shortness of breath, wheezing, cough)
• Hemolytic-uremic syndrome (Changes in the volume or colour of urine, increased bruising, or bleeding)
• Pain or tenderness in the upper abdomen
• Allergic reactions, rashes, fever, swelling or sores in the mouth

• Nausea, vomiting
• Low blood cell count
• Loss of appetite
• Hair loss
• Swelling of ankles, feet, and fingers
• Insomnia
• Constipation, diarrhea
• Headache
• Runny nose, chills
• Muscle pain, back pain
• Sweating
• hair loss
• liver problems
• blood in urine
• abnormal urine test
• Oedema (swelling of ankles, fingers, feet, face)

Strength	1 g
Dose/Strength	1000 mg
Injection Type	Solution
Composition	Gemcitabine HCl
Packaging Size	Vial
Brand	Gemcite
Route	IV Infusion
Packaging Type	Vial
Storage Condition	Store at 30 degree Celsius
Prescription/Non prescription	Prescription
Manufacturer	Eli Lilly and Company India Pvt Ltd
Form	Injection
Shelf Life	24 Months
Usage/Application	Hospital
Usage	Ovarian Cancer, Bladder Cancer, Breast Cancer, NSCLC, Pancreatic Ca
Country of Origin	Made in India

Gemcite 1gm injection is a chemotherapy medication containing the active ingredient gemcitabine. It is used to treat bladder cancer, breast cancer, ovarian cancer, pancreatic cancer, and non-small cell lung cancer. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. Talk to your doctor if you have heart disease, liver disorders, kidney disorders, recently had radiotherapy, or vaccinated before taking this medicine. 

Gemcite 1gm injection is not recommended for adolescents and children under the age of 18. Your doctor will assess your blood cell counts and kidney and liver function each time you are given this medicine. Use effective birth control during the treatment and at least six months after the last dose. This injection may impair fertility in male patients. Men taking this medicine are advised not to father a child during the treatment and for 6 months after the treatment. 

Tell your physician if you are on a salt-controlled diet, as this medicine contains sodium. Report to your doctor immediately if you experience shortness of breath, wheezing, changes in color or volume of urine, bleeding, or upper abdominal pain while taking Gemcite 1gm injection.

Uses

Gemcite 1gm injection is used to treat

• Bladder cancer, in combination with cisplatin
• Ovarian cancer, in combination with carboplatin
• Breast cancer, in combination with paclitaxel
• Pancreatic cancer
• Non-small cell lung cancer (NSCLC), alone or in combination with cisplatin

More Information

• Keep Gemcite 1gm injection out of sight and reach of children.
• This medicine does not require any special storage conditions.
• Do not refrigerate or freeze.

Safety Advices Pregnancy  

Gemcite 1gm injection can cause harm to your unborn baby. Tell your doctor if you are pregnant or planning to get pregnant before taking this treatment.   

Breast Feeding  

You must not breastfeed while being treated with Gemcite 1gm injection. Inform your doctor if you are breastfeeding before taking this injection.  

Lungs  

Gemcite 1gm injection is used cautiously in a patient with a lung disorder. Inform your doctor if you have any lung disease.   

Liver  

You need to tell your doctor if you have any liver disorders before taking Gemcite 1gm injection. Your doctor may decide to adjust the dose or delay treating you depending on your liver function.  

Alcohol  

It is not advised to take alcohol while under this treatment because Gemcite 1gm may cause drowsiness and sleepiness.  Talk to your doctor for more information.  

Driving  

Gemcite 1gm injection could affect your ability to drive. Avoid driving while taking this medicine. Talk to your doctor for more information. 

Side Effects

• Pulmonary toxicity (shortness of breath, wheezing, cough)
• Hemolytic-uremic syndrome (Changes in the volume or colour of urine, increased bruising, or bleeding)
• Pain or tenderness in the upper abdomen
• Allergic reactions, rashes, fever, swelling or sores in the mouth

• Nausea, vomiting
• Low blood cell count
• Loss of appetite
• Hair loss
• Swelling of ankles, feet, and fingers
• Insomnia
• Constipation, diarrhea
• Headache
• Runny nose, chills
• Muscle pain, back pain
• Sweating
• hair loss
• liver problems
• blood in urine
• abnormal urine test
• Oedema (swelling of ankles, fingers, feet, face)

Strength	200 mg
Brand	Azacytin
Packaging Size	14 Tablets
Dose Type	Oral
Form	Tablet
Indication	AML
Storage Condition	Store below 30 DegreeC
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Azacytin 200mg Tablet for Tablet is used for treating adults with Myelodysplastic syndrome (MDS) and Acute myeloid leukemia (AML) if they are considered ineligible for stem cell transplant. In Myelodysplastic Syndrome, the bone marrow does not produce healthy blood cells due to its lack of function. Acute Myeloid Leukemia is a type of bone marrow cancer that is caused by the release of incompletely formed blood cells into the bloodstream.

Uses of Azacytin 200mg Tablet

• Treatment of Acute Myeloid Leukemia with 20-30% blasts in patients who are not eligible for Haemopoietic stem cell transplant
• Intermediate-2 and High-risk Myelodysplastic syndrome (MDS)

Therapeutic Effects of Azacytin 200mg Tablet

In MDS and AML, the development of tumor cells is caused by the process of transcriptional repression of various genes, which is due to the hypermethylation of DNA. Transcriptional repression is a process where proteins bind directly or indirectly to DNA and control the activity of copying a specific gene or a set of genes. The active form of Azacytin 200mgTablet binds to RNA and DNA, interrupts their activity in actively multiplying cells, and exhibits a toxic effect on cancer cells.

Interaction of Azacytin 200mg Tablet with other drugs

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Azacytin 200mg Tablet and cause undesirable side effects. 

More Information about Azacytin 200mg Tablet

Store at room temperature (15-30°C). If the product is reconstituted, it must be used immediately; if not, store at 2-8°C for not more than 8 hours. Keep the Tablet out of sight and reach of children.

Safety Advices   Pregnancy  

Azacytin 200mg Tablet could be harmful to the unborn fetus. Inform your physician if you are pregnant or planning to get pregnant.   

Breast Feeding  

Breastfeeding is not intended for patients on Azacytin 200mg Tablet therapy. Consult your physician for advice.  

Lungs  

It is not known whether it is safe to administer Azacytin 200mg Tablet in lung failure patients. Please consult your doctor.  

Liver  

Inform your physician if you have been told that you have a tumor in the liver cells.  

Alcohol  

It is not known whether it is safe to consume alcohol with Azacytin 200mg Tablet. Please consult your doctor.  

Driving  

It is unsafe to drive after taking this Tablet as it causes dizziness and patients lack concentration and alertness. So, avoid driving and handling heavy machinery after taking Azacytin 200mg Tablet.

Side Effects

• Unexpected bleeding, with blood in stool and urine
• Fever
• Pneumonia, is characterized by chest pain or breathlessness.
• Allergic reaction with symptoms of swelling of lips, itching, or rashes.
• Seizures, loss of consciousness, severe headache, or bleeding in the brain
• Frequent urination with pain or burning sensation

• Disturbances in the blood count (RBC, WBC, Platelets)
• Nausea, vomiting, diarrhea
• Constipation
• Tiredness
• Skin reactions like redness and pain at the site of Tablet
• Decreased appetite
• Dizziness
• Pain in extremities
• Joint pain
• Stomach pain
• Headache
• Sore nose and throat
• Rashes and bruising

Strength	200 mg
Brand	Azashine
Packaging Size	14 Tablets
Form	Tablet
Dose Type	Oral
Indication	AML
Storage Condition	Store below 30 DegreeC
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Azashine 200mg Tablet for Tablet is used for treating adults with Myelodysplastic syndrome (MDS) and Acute myeloid leukemia (AML) if they are considered ineligible for stem cell transplant. In Myelodysplastic Syndrome, the bone marrow does not produce healthy blood cells due to its lack of function. Acute Myeloid Leukemia is a type of bone marrow cancer that is caused by the release of incompletely formed blood cells into the bloodstream.

Uses of Azashine 200mg Tablet

• Treatment of Acute Myeloid Leukemia with 20-30% blasts in patients who are not eligible for Haemopoietic stem cell transplant
• Intermediate-2 and High-risk Myelodysplastic syndrome (MDS)

Therapeutic Effects of Azashine 200mg Tablet

In MDS and AML, the development of tumor cells is caused by the process of transcriptional repression of various genes, which is due to the hypermethylation of DNA. Transcriptional repression is a process where proteins bind directly or indirectly to DNA and control the activity of copying a specific gene or a set of genes. The active form of Azashine 200mgTablet binds to RNA and DNA, interrupts their activity in actively multiplying cells, and exhibits a toxic effect on cancer cells.

Interaction of Azashine 200mg Tablet with other drugs

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Azashine 200mg Tablet and cause undesirable side effects. 

More Information about Azashine 200mg Tablet

Store at room temperature (15-30°C). If the product is reconstituted, it must be used immediately; if not, store at 2-8°C for not more than 8 hours. Keep the Tablet out of sight and reach of children.

Safety Advices   Pregnancy  

Azashine 200mg Tablet could be harmful to the unborn fetus. Inform your physician if you are pregnant or planning to get pregnant.   

Breast Feeding  

Breastfeeding is not intended for patients on Azashine 200mg Tablet therapy. Consult your physician for advice.  

Lungs  

It is not known whether it is safe to administer Azashine 200mg Tablet in lung failure patients. Please consult your doctor.  

Liver  

Inform your physician if you have been told that you have a tumor in the liver cells.  

Alcohol  

It is not known whether it is safe to consume alcohol with Azashine 200mg Tablet. Please consult your doctor.  

Driving  

It is unsafe to drive after taking this Tablet as it causes dizziness and patients lack concentration and alertness. So, avoid driving and handling heavy machinery after taking Azashine 200mg Tablet.

Side Effects

• Unexpected bleeding, with blood in stool and urine
• Fever
• Pneumonia, is characterized by chest pain or breathlessness.
• Allergic reaction with symptoms of swelling of lips, itching, or rashes.
• Seizures, loss of consciousness, severe headache, or bleeding in the brain
• Frequent urination with pain or burning sensation

• Disturbances in the blood count (RBC, WBC, Platelets)
• Nausea, vomiting, diarrhea
• Constipation
• Tiredness
• Skin reactions like redness and pain at the site of Tablet
• Decreased appetite
• Dizziness
• Pain in extremities
• Joint pain
• Stomach pain
• Headache
• Sore nose and throat
• Rashes and bruising

Strength	200 mg
Brand	Hemazide-O
Packaging Size	14 Tablets
Dose Type	Oral
Form	Tablet
Indication	AML
Storage Condition	Store below 30 DegreeC
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Hemazide O 200mg Tablet for Tablet is used for treating adults with Myelodysplastic syndrome (MDS) and Acute myeloid leukemia (AML) if they are considered ineligible for stem cell transplant. In Myelodysplastic Syndrome, the bone marrow does not produce healthy blood cells due to its lack of function. Acute Myeloid Leukemia is a type of bone marrow cancer that is caused by the release of incompletely formed blood cells into the bloodstream.

Uses of Hemazide O 200mg Tablet

• Treatment of Acute Myeloid Leukemia with 20-30% blasts in patients who are not eligible for Haemopoietic stem cell transplant
• Intermediate-2 and High-risk Myelodysplastic syndrome (MDS)

Therapeutic Effects of Hemazide O 200mg Tablet

In MDS and AML, the development of tumor cells is caused by the process of transcriptional repression of various genes, which is due to the hypermethylation of DNA. Transcriptional repression is a process where proteins bind directly or indirectly to DNA and control the activity of copying a specific gene or a set of genes. The active form of Hemazide O 200mgTablet binds to RNA and DNA, interrupts their activity in actively multiplying cells, and exhibits a toxic effect on cancer cells.

Interaction of Hemazide O 200mg Tablet with other drugs

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Hemazide O 200mg Tablet and cause undesirable side effects. 

More Information about Hemazide O 200mg Tablet

Store at room temperature (15-30°C). If the product is reconstituted, it must be used immediately; if not, store at 2-8°C for not more than 8 hours. Keep the Tablet out of sight and reach of children.

Safety Advices   Pregnancy  

Hemazide O 200mg Tablet could be harmful to the unborn fetus. Inform your physician if you are pregnant or planning to get pregnant.   

Breast Feeding  

Breastfeeding is not intended for patients on Hemazide O 200mg Tablet therapy. Consult your physician for advice.  

Lungs  

It is not known whether it is safe to administer Hemazide O 200mg Tablet in lung failure patients. Please consult your doctor.  

Liver  

Inform your physician if you have been told that you have a tumor in the liver cells.  

Alcohol  

It is not known whether it is safe to consume alcohol with Hemazide O 200mg Tablet. Please consult your doctor.  

Driving  

It is unsafe to drive after taking this Tablet as it causes dizziness and patients lack concentration and alertness. So, avoid driving and handling heavy machinery after taking Hemazide O 200mg Tablet.

Side Effects

• Unexpected bleeding, with blood in stool and urine
• Fever
• Pneumonia, is characterized by chest pain or breathlessness.
• Allergic reaction with symptoms of swelling of lips, itching, or rashes.
• Seizures, loss of consciousness, severe headache, or bleeding in the brain
• Frequent urination with pain or burning sensation

• Disturbances in the blood count (RBC, WBC, Platelets)
• Nausea, vomiting, diarrhea
• Constipation
• Tiredness
• Skin reactions like redness and pain at the site of Tablet
• Decreased appetite
• Dizziness
• Pain in extremities
• Joint pain
• Stomach pain
• Headache
• Sore nose and throat
• Rashes and bruising

Treatment Type	Breast Cancer
Dosage Form	Injection
Brand	Dr. Reddy's
Strength	3.75mg
Packaging Type	Vial
Composition	Triptorelin
Packaging Size	1 Vial
Form	Injection
Route of Administration	IM
Storage Condition	Store below 30 DegreeC
Prescription/Non prescription	Prescription
Manufacturer	Dr Reddy's
Country of Origin	Made in India

Pamorelin 3.75mg injection contains an active component as Triptorelin.  It is a medication that belongs to a class of drugs known as gonadotropin-releasing hormone (GnRH) analogs. It is primarily used in the field of reproductive medicine for the treatment of various conditions related to hormonal imbalance. One of the most common use is in treating certain hormone-dependent conditions such as prostate cancer, breast cancer, and endometriosis. In prostate cancer, for example, this medication is used to lower the levels of testosterone, which can help slow down the growth of cancer cells.

Uses

• Prostate cancer in men
• Early onset puberty in children 2 years of age and older (precocious puberty)

More Information

• Store at room temperature, between 20°C to 25°C (68°F to 77°F).
• Keep away from moisture, heat, and light.
• It should not be frozen.
• Keep away from children and pets.  

Safety Advices Pregnancy  

Pamorelin 3.75mg injection is generally not recommended for use during pregnancy. If pregnancy is planned or suspected while using this medication, it is important to inform the healthcare professional promptly. They can provide appropriate guidance and make necessary adjustments to the treatment plan.   

Breast Feeding  

The safety of Pamorelin 3.75mg injection during breastfeeding is not well established. It is advisable to avoid using it while breastfeeding unless the potential benefits outweigh the potential risks to the nursing infant.  

Lungs  

Pamorelin 3.75mg injection is generally considered safe for use in individuals with lung conditions. However, as with any medication, it is important to consult with a healthcare professional before starting this medication if you have a lung condition or any respiratory issues.  

Liver  

Pamorelin 3.75mg injection should be used with caution in individuals with liver impairment or liver disease. The metabolism and elimination of this medication may be affected in such cases. However, there is limited information available specifically regarding the safety in patients with liver conditions.  

Alcohol  

The use of Pamorelin 3.75mg injection in combination with alcohol is not well studied, and there is limited information available specifically regarding the interaction between this medication and alcohol. Therefore, it is generally recommended to exercise caution and avoid excessive alcohol consumption while using it.  

Driving  

Common side effects of Pamorelin 3.75mg injection may include hot flashes, mood changes, and fatigue. If any of these side effects occur and significantly impact your alertness, concentration, or motor skills, it is advisable to avoid driving or operating machinery until you feel capable of doing so safely.

Side Effects

• Swallowing or breathing trouble
• Increased lymphocyte count in the blood
• Swelling of lips, tongue or throat

• Hot flushes
• Weakness
• Excessive sweating
• Back pain
• Impotence
• Nausea
• Dry mouth
• Pain, bruising, redness at the injection site
• High blood pressure
• Weight gain
• Dizziness
• Headache

Composition	Emend Fosaprepitant Dimeglumine
Strength	150mg/ml
Pack size	1 ml
Usage/Application	Hospital
Brand	Emend
Route	IV
Usage	Hospital
Dose	150mg
Drug Name	Fosaprepitant Dimeglumine
Product Type	Finished Product
Packaging Size	1's
Form	Injection
Packaging Type	Vial
Shelf life	24 months
Storage	Below 25°C
Injectable Form	Injection
Manufactured By	MSD Pharmaceuticals Pvt Ltd
Country of Origin	Made in India

Emend 150mg Injection is used to treat vomiting and nausea. It is commonly used to control the acute and delayed nausea and vomiting associated with cancer treatment, including high-dose cisplatin (highly emetogenic) and moderately nauseating cancer chemotherapy. The contraceptives fail to work efficaciously during the treatment with Emend 150mg Injection.  

Concomitant administration of warfarin significantly alters the blood clotting time, so it is necessary to monitor the patients on chronic warfarin therapy before initiating Emend 150mg Injection. It is contraindicated in hypersensitive individuals. The dosage regimen includes the use of oral dexamethasone in the treatment. Inform your physician if you have any diseases. Inform your doctor if you are on warfarin therapy and contraceptive medication.

Uses of Emend 150mg Injection

• High emetogenic cancer chemotherapy
• Moderately emetogenic cancer chemotherapy

Therapeutic Effects of Emend 150mg Injection

Emend 150 mg injection works by acting on the receptors responsible for nausea and vomiting, antagonizing the substances involved.

Interaction of Emend 150mg Injection with other drugs

Inform your doctor about any prescribed medications, over-the-counter medications, nutritional and vitamin supplements, or herbal products that you are taking or have taken before the treatment. Certain medications tend to interact with Emend 150 mg injection and cause undesirable side effects.

More Information

The vials should be stored between 2°-8° C.

Safety Advices Pregnancy  

There are no established adverse effects of the Emend 150mg Injection during the administration of pregnancy. It is advisable to take it only under specialist advice on necessary requirements. Consult your doctor about the potential risks of this medication.   

Breast Feeding  

There are no established adverse effects of the Emend 150mg Injection during breastfeeding. Inform your physician if you are breastfeeding before taking this medicine.  

Lungs  

It is unknown whether Emend 150 mg injection is safe when administered in lung failure patients. Please consult the doctor if you have any lung problems.  

Liver  

Emend 150 mg Injection should be used with caution in patients with severe liver disease. Dose adjustment may be needed. Please consult your doctor. No dose adjustment is recommended in patients with moderate to severe liver disease.  

Alcohol  

It is unsafe to consume alcohol with Emend 150mg Injection. Please consult your doctor.  

Driving  

The medicine may make you dizzy; avoid driving or handling heavy machines if you are unwell. Consult your physician for more advice.

Side Effects

• Skin blistering, peeling
• Low white blood cell count
• Anemia
• Severe allergic reaction
• Urinary tract infection
• Pain in extremity
• Abnormal physical weakness
• Nerve damage

• Fatigue
• constipation
• Indigestion, diarrhea
• Rash, urticaria
• Loss of appetite
• hiccups

Strength	150 mg/vial
Pack Type	Vial
Brand	Aprecap
Packaging Type	Vial
Route	IV
Usage	Chemo Induced Nausea
Dilution Form	Lyophilized Powder
Also gives	PCD Pharma
Manufactured By	Glenmark Pharmaceuticals Ltd
Prescription/Non Prescription	Prescription
Country of Origin	Made in India

Aprecap 150mg Injection is used to treat vomiting and nausea. It is commonly used to control the acute and delayed nausea and vomiting associated with cancer treatment, including high-dose cisplatin (highly emetogenic) and moderately nauseating cancer chemotherapy. The contraceptives fail to work efficaciously during the treatment with Emend 150mg Injection.

Uses

• High emetogenic cancer chemotherapy
• Moderately emetogenic cancer chemotherapy

More Information

The vials should be stored between 2°-8° C.

Safety Advices  

Pregnancy  

There are no established adverse effects of the Aprecap 150mg Injection during the administration of pregnancy. It is advisable to take it only under specialist advice on necessary requirements. Consult your doctor about the potential risks of this medication.   

Breast Feeding

There are no established adverse effects of the Aprecap 150mg Injection during breastfeeding. Inform your physician if you are breastfeeding before taking this medicine.  

Lungs  

It is unknown whether Aprecap 150 mg injection is safe when administered in lung failure patients. Please consult the doctor if you have any lung problems.  

Liver  

Aprecap 150 mg Injection should be used with caution in patients with severe liver disease. Dose adjustment may be needed. Please consult your doctor. No dose adjustment is recommended in patients with moderate to severe liver disease.  

Alcohol  

It is unsafe to consume alcohol with Aprecap 150mg Injection. Please consult your doctor.  

Driving 

The medicine may make you dizzy; avoid driving or handling heavy machines if you are unwell. Consult your physician for more advice.

Side Effects

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.

• Skin blistering, peeling
• Low white blood cell count
• Anemia
• Severe allergic reaction
• Urinary tract infection
• Pain in extremity
• Abnormal physical weakness
• Nerve damage

• Fatigue
• constipation
• Indigestion, diarrhea
• Rash, urticaria
• Loss of appetite
• hiccups

Composition	Fosaprepitant Dimeglumine
Strength	150mg/ml
Pack size	1 ml
Usage/Application	Hospital
Brand	Fosa
Route	IV
Usage	Hospital
Dose	150mg
Drug Name	Fosaprepitant Dimeglumine 150mg
Product Type	Finished Product
Packaging Size	1's
Form	Injection
Packaging Type	Injection Vial
Shelf life	24 months
Storage	Below 25°C
Injectable Form	Injection
Manufactured By	Mylan Pharmaceuticals Pvt Ltd - A Viatris Company
Country of Origin	Made in India

Fosa 150mg Injection is used to treat vomiting and nausea. It is commonly used to control the acute and delayed nausea and vomiting associated with cancer treatment, including high-dose cisplatin (highly emetogenic) and moderately nauseating cancer chemotherapy. The contraceptives fail to work efficaciously during the treatment with Fosa 150mg Injection.  

Concomitant administration of warfarin significantly alters the blood clotting time, so it is necessary to monitor the patients on chronic warfarin therapy before initiating Fosa 150mg Injection. It is contraindicated in hypersensitive individuals. The dosage regimen includes the use of oral dexamethasone in the treatment. Inform your physician if you have any diseases. Inform your doctor if you are on warfarin therapy and contraceptive medication.

Uses of Fosa 150mg Injection

• High emetogenic cancer chemotherapy
• Moderately emetogenic cancer chemotherapy

Therapeutic Effects of Fosa 150mg Injection

Fosa 150 mg injection works by acting on the receptors responsible for nausea and vomiting, antagonizing the substances involved.

Interaction of Fosa 150mg Injection with other drugs

Inform your doctor about any prescribed medications, over-the-counter medications, nutritional and vitamin supplements, or herbal products that you are taking or have taken before the treatment. Certain medications tend to interact with Fosa 150 mg injection and cause undesirable side effects.

More Information about Fosa 150mg Injection

The vials should be stored between 2°-8° C.

How to consume Fosa 150mg Injection

Fosa 150 mg injection will be administered to you by a health care professional. Do not self-administer. Your doctor will decide your dose and duration of the therapy.

Safety Advices Pregnancy  

There are no established adverse effects of the Fosa 150mg Injection during the administration of pregnancy. It is advisable to take it only under specialist advice on necessary requirements. Consult your doctor about the potential risks of this medication.   

Breast Feeding

There are no established adverse effects of the Fosa 150mg Injection during breastfeeding. Inform your physician if you are breastfeeding before taking this medicine.  

Lungs  

It is unknown whether Fosa 150 mg injection is safe when administered in lung failure patients. Please consult the doctor if you have any lung problems.  

Liver  

Fosa 150 mg Injection should be used with caution in patients with severe liver disease. Dose adjustment may be needed. Please consult your doctor. No dose adjustment is recommended in patients with moderate to severe liver disease.  

Alcohol

It is unsafe to consume alcohol with Fosa 150mg Injection. Please consult your doctor.  

Driving  

The medicine may make you dizzy; avoid driving or handling heavy machines if you are unwell. Consult your physician for more advice.

Side Effects

• Skin blistering, peeling
• Low white blood cell count
• Anemia
• Severe allergic reaction
• Urinary tract infection
• Pain in extremity
• Abnormal physical weakness
• Nerve damage

• Fatigue
• constipation
• Indigestion, diarrhea
• Rash, urticaria
• Loss of appetite
• hiccups